Title
of each class
|
Name
of each exchange on which registered
|
Subordinate
Voting Shares without par value
|
NASDAQ
|
Subordinate
Voting Shares without par value
|
TSX
|
Large
accelerated filer o
|
Accelerated
filer x
|
Non-accelerated
filer o
|
Identity
of
Directors, Senior Management and
Advisors
|
Offer
Statistics and Expected
Timetable
|
Key
Information
|
Years
ended August 31,
|
||||||||||||||||||||
2007
|
2006
|
2005
|
2004
|
2003
|
||||||||||||||||
(in
thousands of US dollars, except share and per share
data)
|
||||||||||||||||||||
Consolidated
Statements of Earnings Data:
|
||||||||||||||||||||
Amounts
under Canadian GAAP
|
||||||||||||||||||||
Sales
|
$ |
152,934
|
$ |
128,253
|
$ |
97,216
|
$ |
74,630
|
$ |
61,930
|
||||||||||
Cost
of sales (1)
|
65,136
|
57,275
|
44,059
|
34,556
|
36,197
|
|||||||||||||||
Gross
margin
|
87,798
|
70,978
|
53,157
|
40,074
|
25,733
|
|||||||||||||||
Operating
expenses
|
||||||||||||||||||||
Selling
and administrative
|
49,580
|
40,298
|
31,782
|
25,890
|
26,991
|
|||||||||||||||
Net
research and development
|
16,668
|
15,404
|
12,190
|
12,390
|
15,879
|
|||||||||||||||
Amortization
of property, plant and equipment
|
2,983
|
3,523
|
4,256
|
4,935
|
5,210
|
|||||||||||||||
Amortization
of intangible assets
|
2,864
|
4,394
|
4,836
|
5,080
|
5,676
|
|||||||||||||||
Impairment
of long-lived assets and goodwill
|
−
|
604
|
−
|
620
|
7,427
|
|||||||||||||||
Government
grants
|
(1,079 | ) | (1,307 | ) |
−
|
−
|
−
|
|||||||||||||
Restructuring
and other charges
|
−
|
−
|
292
|
1,729
|
4,134
|
|||||||||||||||
Total
operating expenses
|
71,016
|
62,916
|
53,356
|
50,644
|
65,317
|
|||||||||||||||
Earnings
(loss) from operations
|
16,782
|
8,062
|
(199 | ) | (10,570 | ) | (39,584 | ) | ||||||||||||
Interest
and other income
|
4,717
|
3,253
|
2,524
|
1,438
|
1,245
|
|||||||||||||||
Foreign
exchange loss
|
(49 | ) | (595 | ) | (1,336 | ) | (278 | ) | (1,552 | ) | ||||||||||
Earnings
(loss) before income taxes
|
21,450
|
10,720
|
989
|
(9,410 | ) | (39,891 | ) | |||||||||||||
Income
taxes
|
(20,825 | ) |
2,585
|
2,623
|
(986 | ) |
15,059
|
|||||||||||||
Net
earnings (loss) for the year
|
$ |
42,275
|
$ |
8,135
|
$ | (1,634 | ) | $ | (8,424 | ) | $ | (54,950 | ) | |||||||
Basic
and diluted net earnings (loss) per share
|
$ |
0.61
|
$ |
0.12
|
$ | (0.02 | ) | $ | (0.13 | ) | $ | (0.87 | ) | |||||||
Basic
weighted average number of shares used in per share calculations
(000’s)
|
68,875
|
68,643
|
68,526
|
66,020
|
62,852
|
|||||||||||||||
Diluted
weighted average number of shares used in per share calculations
(000’s)
|
69,555
|
69,275
|
68,526
|
66,020
|
62,852
|
|||||||||||||||
Other
consolidated statements of earnings data:
|
||||||||||||||||||||
Gross
research and development
|
$ |
25,201
|
$ |
19,488
|
$ |
15,878
|
$ |
15,668
|
$ |
17,133
|
||||||||||
Net
research and development
|
$ |
16,668
|
$ |
15,404
|
$ |
12,190
|
$ |
12,390
|
$ |
15,879
|
||||||||||
Amounts
under U.S. GAAP
|
||||||||||||||||||||
Net
earnings (loss) for the
year
|
$ |
42,257
|
$ |
8,135
|
$ | (2,920 | ) | $ | (9,571 | ) | $ | (48,201 | ) | |||||||
Basic
and diluted net earnings (loss) per
share
|
$ |
0.61
|
$ |
0.12
|
$ | (0.04 | ) | $ | (0.14 | ) | $ | (0.77 | ) | |||||||
Basic
weighted average number of shares used in per share calculations
(000’s)
|
68,875
|
68,643
|
68,526
|
66,020
|
62,852
|
|||||||||||||||
Diluted
weighted average number of shares used in per share calculations
(000’s)
|
69,555
|
69,275
|
68,526
|
66,020
|
62,852
|
As
at August 31,
|
||||||||||||||||||||
2007
|
2006
|
2005
|
2004
|
2003
|
||||||||||||||||
(in
thousands of US dollars)
|
||||||||||||||||||||
Consolidated
Balance Sheets Data:
|
||||||||||||||||||||
Amounts
under Canadian GAAP
|
||||||||||||||||||||
Cash
|
$ |
5,541
|
$ |
6,853
|
$ |
7,119
|
$ |
5,159
|
$ |
5,366
|
||||||||||
Short-term
investments
|
124,217
|
104,437
|
104,883
|
83,969
|
52,010
|
|||||||||||||||
Working
capital
|
180,440
|
143,985
|
135,288
|
115,141
|
77,408
|
|||||||||||||||
Total
assets
|
279,138
|
219,159
|
190,957
|
172,791
|
146,254
|
|||||||||||||||
Long-term
debt (excluding current
portion)
|
−
|
354
|
198
|
332
|
453
|
|||||||||||||||
Share
capital
|
150,019
|
148,921
|
521,875
|
521,733
|
492,452
|
|||||||||||||||
Shareholders’
equity
|
$ |
250,165
|
$ |
196,234
|
$ |
173,400
|
$ |
157,327
|
$ |
129,826
|
||||||||||
Amounts
under U.S. GAAP
|
||||||||||||||||||||
Cash
|
$ |
5,541
|
$ |
6,853
|
$ |
7,119
|
$ |
5,159
|
$ |
5,366
|
||||||||||
Short-term
investments
|
124,217
|
104,437
|
104,883
|
83,969
|
52,010
|
|||||||||||||||
Working
capital
|
183,231
|
149,436
|
138,225
|
117,116
|
78,974
|
|||||||||||||||
Total
assets
|
268,389
|
212,702
|
182,852
|
164,758
|
138,020
|
|||||||||||||||
Long-term
debt (excluding current
portion)
|
−
|
354
|
198
|
332
|
453
|
|||||||||||||||
Share
capital
|
599,519
|
598,421
|
597,664
|
596,309
|
565,291
|
|||||||||||||||
Shareholders’
equity
|
$ |
239,343
|
$ |
189,777
|
$ |
165,295
|
$ |
149,294
|
$ |
121,592
|
(1)
|
The
cost of sales is exclusive of amortization, shown
separately.
|
·
|
increased
competition for business;
|
·
|
reduced
demand;
|
·
|
limited
number of potential customers;
|
·
|
competition
from companies with lower production costs, including companies operating
in lower cost environments;
|
·
|
introduction
of new products by competitors;
|
·
|
greater
economies of scale for higher-volume
competitors;
|
·
|
large
customers, who buy in high volumes, can exert substantial negotiating
leverage over us; and
|
·
|
resale
of used equipment.
|
·
|
costly
repairs;
|
·
|
product
returns or recalls;
|
·
|
damage
to our brand reputation;
|
·
|
loss
of customers, failure to attract new customers or achieve market
acceptance;
|
·
|
diversion
of development and engineering
resources;
|
·
|
legal
actions by our customers, including claims for consequential damages
and
loss of profits; and
|
·
|
legal
actions by governmental entities, including actions to impose product
recalls and/or forfeitures.
|
·
|
issue
shares that would dilute individual shareholder percentage
ownership;
|
·
|
incur
debt;
|
·
|
assume
liabilities and commitments;
|
·
|
incur
significant expenses related to amortization of additional intangible
assets;
|
·
|
incur
significant impairment losses of goodwill and intangible assets related
to
such acquisitions; and
|
·
|
incur
losses from operations.
|
·
|
risk
of not realizing the expected benefits or synergies of such
acquisitions;
|
·
|
problems
integrating the acquired operations, technologies, products and
personnel;
|
·
|
risks
associated with the transfer of acquired know-how and
technology;
|
·
|
unanticipated
costs or liabilities;
|
·
|
diversion
of management’s attention from our core
business;
|
·
|
adverse
effects on existing business relationships with suppliers and
customers;
|
·
|
risks
associated with entering markets in which we have no or limited prior
experience; and
|
·
|
potential
loss of key employees, particularly those of acquired
organizations.
|
·
|
challenges
in staffing and managing foreign operations due to the limited number
of
qualified candidates, employment laws and business practices in foreign
countries, any of which could increase the cost and reduce the efficiency
of operating in foreign countries;
|
·
|
our
inability to comply with import/export, environmental and other trade
compliance regulations of the countries in which we do business,
together
with unexpected changes in such
regulations;
|
·
|
measures to
ensure that we design, implement and maintain adequate controls over
our
financial processes and reporting in the future, especially in light
of
setting up new operating companies in India and China or the likely
future
acquisition of companies;
|
·
|
failure
to adhere to laws, regulations and contractual obligations relating
to
customer contracts in various
countries;
|
·
|
difficulties
in establishing and enforcing our intellectual property
rights;
|
·
|
inability
to maintain a competitive list of distributors for indirect
sales;
|
·
|
tariffs
and other trade barriers;
|
·
|
economic
instability in foreign markets;
|
·
|
wars,
acts of terrorism and political
unrest;
|
·
|
language
and cultural barriers;
|
·
|
lack
of integration of foreign
operations;
|
·
|
currency
fluctuations;
|
·
|
potential
foreign and domestic tax
consequences;
|
·
|
technology
standards that differ from those on which our products are based,
which
could require expensive redesign and retention of personnel familiar
with
those standards;
|
·
|
longer
accounts receivable payment cycles and possible difficulties in collecting
payments which may increase our operating costs and hurt our financial
performance; and
|
·
|
Failure
to meet certification requirements.
|
·
|
length
of the product sales cycle for certain products, especially those
that are
higher priced and more complex;
|
·
|
timing
of product launches and market acceptance of new products for us
as well
as our competitors;
|
·
|
our
ability to sustain product volumes and high levels of quality across
all
product lines;
|
·
|
timing
of shipments for large orders;
|
·
|
effect
of seasonality on sales and bookings;
and
|
·
|
losing
key accounts and not successfully developing new
ones.
|
·
|
fluctuating
demand for telecommunications test and measurement equipment as well
as
life sciences and industrial
solutions;
|
·
|
changes
in the capital spending and operating budgets of our customers, which
may
cause seasonal or other fluctuations in product mix, volume, timing
and
number of orders we receive from our
customers;
|
·
|
order
cancellations or rescheduled delivery
dates;
|
·
|
pricing
changes by our competitors or
suppliers;
|
·
|
customer
bankruptcies and difficulties in collecting accounts
receivable;
|
·
|
restructuring
and impairment charges;
|
·
|
foreign
exchange rate fluctuations, as a portion of our operating expenses
are
denominated in Canadian dollars;
and
|
·
|
general
economic conditions.
|
·
|
properly
identify and anticipate customer
needs;
|
·
|
innovate
and develop new products;
|
·
|
gain
timely market acceptance for new
products;
|
·
|
manufacture
and deliver our new products on time and in sufficient
volume;
|
·
|
price
our products competitively;
|
·
|
continue
investing in our research and development programs;
and
|
·
|
anticipate
competitors’ announcements of new
products.
|
Information
of
the Company
|
·
|
Increase
sales through market-share gains. We plan on increasing
sales with a 20% growth target for fiscal 2008. We believe
that we can
continue gaining market share based on our strong positioning
for key
growth trends, such as the deployment of fiber deeper into
access networks
and the migration of networks towards converged, IP architectures;
our
history of gaining market share as evidenced by four consecutive
Growth
Strategy Leadership Awards from Frost & Sullivan for largest market
share gains in optical testing; strong focus on execution as
demonstrated
by a sales compound annual growth rate of 27.0% over the last
three years
and 20.1% over the last 10 years, as well as ongoing investments
on global
sales and marketing staff.
|
·
|
Maximize
profitability. We will strive to generate a GAAP
operating margin of 8% in 2008, even considering a moderate strengthening
of the Canadian dollar and our global expansion plans. We will
seek to
accomplish this through higher sales volumes enabling us to better
absorb
our fixed manufacturing costs, increased sales of higher-margin
protocol
test solutions, and a lower cost structure with some manufacturing
and
R&D being carried out in China and India,
respectively.
|
·
|
Focus
on innovation. We will seek to derive at least 30% of sales from
new products that have been on the market two years or less in
fiscal
2008. It remains an aggressive target, because we are usually first
to
market with our new products to quickly capture market share.
Consequently, at the time when our new products are receiving global
market acceptance, they often cross the two-year threshold for
new
products. The average lifecycle of a product is about five years.
We
believe this innovation metric is critical for us because it measures
the
effectiveness of our market-driven innovation
program.
|
·
|
unlike
stand-alone units, new test modules can be rapidly developed to address
changing industry requirements;
|
·
|
as
customers’ testing requirements change, they can purchase additional
modules that are compatible with their previously purchased platforms,
thus protecting their initial
investments;
|
·
|
our
standard graphical user interface reduces training costs because
customers
are familiar with previously acquired software
products;
|
·
|
the
flexibility of our systems allows customers to develop customized
and
automated solutions for their specific test
requirements;
|
·
|
our
test platforms are PC-based and Windows-driven, thus they can support
third-party software solutions.
|
·
|
the
first PC-based modular test platform for field
applications;
|
·
|
the
first all-in-one optical loss test set combining several
instruments;
|
·
|
the
first portable polarization mode dispersion (PMD)
analyzer;
|
·
|
the
first modular platform to combine optical and protocol test
solutions;
|
·
|
the
first line of portable test instruments designed for FTTx testing;
and
|
·
|
the
first fully integrated Ethernet-over-SONET test
solution.
|
Instrument
Type
|
Typical
Application
|
NSP
Market
|
Manufacturer
/R&D
Market
|
||||
FTB
400 Modules
|
FTB
200 Modules
|
AXS
200 Modules
|
Handhelds
|
IQS-500
Modules
|
Benchtop
Instruments
|
||
ADSL/ADSL2+
Service Verification Tool
|
Based
on a DSL “golden modem”, these units are used to test the function, speed
and quality of a DSL service at the subscriber premises.
|
X
|
X
|
||||
Broadband
source
|
Used
for testing wavelength-dependent behavior of fiber cables and dense
wavelength division multiplexing (DWDM) optical
components.
|
X
|
X
|
||||
Chromatic
dispersion analyzer
|
Measures
increasing levels of chromatic dispersion in high-capacity optical
networks. Chromatic dispersion is a physical phenomenon
inherent to optical fiber and optical components that causes information
bits to spread along a network. This degrades the quality of
the transmission signal and, in turn, limits the transmission speed
carried by optical networks.
|
X
|
|||||
Clip-on
coupling device
|
Clips
to an optical fiber and allows non-invasive testing.
|
X
|
|||||
Fibre
Channel tester
|
Brings
FC-0, FC-1 and FC-2 logical layer Fibre Channel testing to services
delivered via transport protocols, such as dense wavelength division
multiplexing (DWDM), SONET/SDH and dark fiber. It provides valuable
timing
information and buffer credit estimation for Fibre Channel network
deployment.
|
X
|
X
|
||||
Gigabit
Ethernet tester
|
Measures
data integrity for high-speed Internet protocol telecommunications
in
metro and edge networks.
|
X
|
X
|
X
|
X
|
||
10
Gigabit Ethernet tester
|
Benchmarks
and verifies high-speed 10 Gbit/s Ethernet network performance and
service-level agreements.
|
X
|
X
|
X
|
|||
HDTV,
SDTV and IPTV service test instrument
|
Used
to test the quality and functionality of standard and high definition
television signals that are delivered over higher-rate ADSL, ADSL2+
and
VDSL2 transmission technologies.
|
X
|
|||||
Laser
wavelength meter
|
Performs
high-accuracy, absolute wavelength measurements of continuous wave
(CW)
laser sources.
|
X
|
|||||
Laser
spectrum analyzer
|
Performs
high-resolution, spectral characterization of continuous CW laser
sources
|
X
|
|||||
Telephone
for traditional voice and VoIP service testing
|
Used
by telephone line and DSL installers to test the proper functioning
of
both traditional and next-generation voice and data communication
services.
|
X
|
Instrument
Type
|
Typical
Application
|
NSP
Market
|
Manufacturer
/R&D
Market
|
||||
FTB
400 Modules
|
FTB
200 Modules
|
AXS
200 Modules
|
Handhelds
|
IQS-500
Modules
|
Benchtop
Instruments
|
||
Live
fiber detector
|
Clips
on to a fiber and is used to detect the presence and direction of
a signal
without interrupting the traffic.
|
X
|
|||||
Loss
test set
|
Integrates
a power meter and a light source to manually or automatically measure
the
loss of optical signal along a fiber.
|
X
|
X
|
X
|
X
|
X
|
|
Multiwavelength
meter
|
Measures
the power and drift for multiple wavelengths in a dense wavelength
division multiplexing (DWDM) system.
|
X
|
X
|
X
|
|||
Narrowly
tunable laser
|
A
laser that can be precisely tuned to simulate a DWDM light
sources. Used primarily for testing optical
amplifiers.
|
X
|
|||||
Next-generation
SONET/SDH analyzer
|
Full
SONET/SDH protocol testing functionality, including support for generic
framing procedure (GFP), virtual concatenation (VCAT), and link-capacity
adjustment scheme (LCAS) next generation enhancements.
|
X
|
X
|
||||
Optical
amplifier
|
Boosts
the power of laser sources. Used for the testing and calibration
of test
systems.
|
X
|
|||||
Optical
coupler
|
Used
in test system to combine sources or signals. Also uses as
splitters to monitor signals.
|
X
|
|||||
Optical
fiber parameter analyzer
|
Measures
the geometric and light guiding properties of an optical fiber. Used
in
new fiber research and development and quality control
applications.
|
X
|
|||||
Optical
power meter
|
Measures
the power of an optical signal. It is the basic tool for the
verification of transmitters, amplifiers and optical transmission
path
integrity.
|
X
|
X
|
X
|
X
|
X
|
|
Optical
power reference module
|
Provides
a highly accurate and traceable measurement of power for the calibration
or verification of other power measurement instruments.
|
X
|
|||||
Optical
return loss meter
|
Combines
a laser and a power meter to measure the amount of potentially degrading
back reflection.
|
X
|
X
|
X
|
X
|
||
Optical
spectrum analyzer
|
Produces
a graphical representation of power versus wavelength for an optical
signal. Useful for measuring the drift, power and signal-to-noise
ratio
for each wavelength in a DWDM system.
|
X
|
|||||
Optical
switch
|
Provides
switching between fibers. Used to provide flexible and automated
test
setups such as the measurement of multiple fibers or components with
multiple ports with one instrument.
|
X
|
X
|
||||
Optical
time domain reflectometer
(OTDR)
|
Like
a radar, it measures the time of arrival of reflections of an optical
signal to determine the distance to the breaks or points of excessive
loss
in a fiber network.
|
X
|
X
|
X
|
|||
Optical
waveguide analyzer
|
Provides
the refractive index profile of glass and fused silica-based devices
used
in next generation networks.
|
X
|
|||||
Passive
component analyzer
|
Characterizes
passive wavelength-selective devices, such as multiplexers, demultiplexers
and add/drop filters, with respect to absolute wavelength in order
to
guarantee their performance within dense wavelength division multiplexing
(DWDM) systems.
|
X
|
|||||
Passive
optical network (PON) power meter
|
Determines
the power level of various signal types, including continuous (e.g.,
TV
signal at 1550 nm) and framed (e.g., ATM or Ethernet at 1490 nm or
1310
nm) within a passive optical network. Various baud rates are covered,
ranging from 155 Mbit/s to 2.5 Gbit/s, for both synchronous and
non-synchronous signals.
|
X
|
Instrument
Type
|
Typical
Application
|
NSP
Market
|
Manufacturer
/R&D
Market
|
||||
FTB
400 Modules
|
FTB
200 Modules
|
AXS
200 Modules
|
Handhelds
|
IQS-500
Modules
|
Benchtop
Instruments
|
||
Polarization-dependent
loss meter
|
Measures
the difference in loss of power for the different states of
polarization.
|
X
|
|||||
Polarization
mode dispersion analyzer
|
Measures
the dispersion of light that is caused by polarization. Generally
used to
determine the speed-distance limitation of fiber and
cables.
|
X
|
|||||
SONET/
SDH analyzer
|
Provides
accurate bit-error rate and performance analysis of SONET/SDH overhead
format that reflects the quality of a transmission system.
|
X
|
X
|
X
|
|||
Stable
light source
|
Emitting
diode or lasers used in connection with a power meter to measure
signal
loss.
|
X
|
X
|
X
|
X
|
||
Synchronization
analyzer
|
Portable,
stand-alone tester for network synchronization analysis and wander
measurement in wireless and wireline transport networks.
|
X
|
|||||
Talk
set
|
A
device that attaches to an optical fiber and serves as a temporary
voice
link facilitating coordination of work among installation
crews.
|
X
|
X
|
||||
Telephone
wire analyzer
|
Used
by telecommunications service providers that have networks that are
comprised mostly or partially of twisted-pair local loops to ensure
that
those loops are of sufficient quality to carry higher-frequency signals
required for DSL.
|
X
|
|||||
Variable
optical attenuator
|
Used
in network simulation setups to provide calibrated variable reduction
of
the strength of an optical signal.
|
X
|
X
|
X
|
|||
Visual
fault locator
|
A
visible laser that can be connected to an optical fiber network to
help
locate breaks or points of excessive loss.
|
X
|
X
|
X
|
|||
Widely
tunable laser
|
Can
produce laser light across a broad range of wavelengths. Used to
test DWDM
components and value-added optical modules.
|
X
|
X
|
· CWDM/FTTH
passive optical component test system
|
Used
to automatically characterize all critical specifications, including
spectral insertion loss, polarization-dependent loss and optical
return
loss of a CWDM passive component or a FTTH splitter with a high degree
of
accuracy, ease of use and speed.
|
· Cable
assembly and component test system
|
Used
to perform insertion loss and mandrel-free reflection measurements
with
the highest degree of accuracy and repeatability on short fiber assemblies
(including multifiber patchcords, hybrids and fan-out patchcords)
and
components like PLC splitters and fiber arrays.
|
· DWDM
passive component test system
|
Used
to automatically characterize all critical specifications, including
spectral insertion loss, polarization-dependent loss and optical
return
loss of a DWDM passive component with a high degree of accuracy,
ease of
use and speed.
|
Light
Sources and Accessories
|
||
Product
Type
|
Product
|
Typical
Application
|
UV
Light Sources
|
Omnicure®
S1000
Omnicure®
S2000
|
Used
to initiate photo chemical reactions in polymer-based materials for a
variety of end use applications. Examples include adhesive curing
for
manufacturing of high value-added items such as medical devices,
micro-electronic and opto-electronic components, displays, and data
storage devices.
|
Fluorescent
Light Sources
|
X-Cite®
120XL
X-Cite®
120 PC
|
Fluorescence
light source that attaches directly to most microscopes currently
sold by
major microscopes manufacturers.
|
Optical
Accessories
|
Optional
custom delivery optics used with EXFO UV light sources to tailor
the
properties of light beams to end-user applications.
|
|
High
Power Fiber Light Guide
|
Provides
an equal distribution of light energy to multiple cure sites with
50% more
throughput than standard fiber guides.
|
|
Optical Instruments
|
||
Product
Type
|
Product
|
Typical
Application
|
Radiometer
|
R5000
R2000
|
Handheld,
broadband optical radiometers used in conjunction with EXFO UV light
sources to ensure process quality control at the end-user
location.
|
Cure-Site
Radiometer
|
|
Attachments
for the R2000 and R5000 radiometers that enable optical measurements
under
customer specific configurations. Examples include the cure-ring
radiometer, which measures the output power of light from an EXFO
cure
ring; ideal for applications that requires a uniform 360°
exposure.
|
Precise
Motors/Stages
|
IW-700
Inchworm Motors
TSE-820
Inchworm Stages
UHVL
Inchworm Motors
|
High-resolution
optical alignment, fiber-optic alignment, semiconductor positioning,
materials research.
|
Precision
Positioning Instruments
|
||
Product
Type
|
Product
Line
|
Typical
Application
|
Micromanipulators
|
PCS-6000
Micromanipulators
PCS-5000
Micromanipulators
|
Electrophysiology
research such as patch clamp recording experiments on cells from
the brain
and central nervous system.
|
Microscope
Platforms
|
Gibraltar
Platform/Stage
|
Stable
mechanical platforms that facilitate cellular research with
micropositioning and microinjection systems.
|
Microinjection
Systems
|
MIS-5000
Microinjection Manipulator
PiezoDrill
Inertial Impact Drill
|
Microinjection
and nuclear transfer for genetics and reproductive sciences
research.
|
Microelectrode
Positioner
|
LSS-8000
Inchworm System
|
Electrophysiology
research such as intracellular recording experiments
|
·
|
market
study and research feasibility;
|
·
|
product
definition;
|
·
|
development
feasibility;
|
·
|
development;
|
·
|
qualification;
and
|
·
|
transfer
to production.
|
·
|
Production. From
production planning to product shipment, our production department
is
responsible for manufacturing high-quality products on time. Factories
are
organized in work cells; each cell consists of specialized technicians
and
equipment and has full responsibility over a product family. Technicians
are cross-trained and versatile enough, so that they can carry out
specific functions in more than one cell. This allows shorter lead
times
by alleviating bottlenecks.
|
·
|
Product
Engineering and Quality. This department, which
supports our production cells, acts like a gatekeeper to ensure the
quality of our products and the effectiveness of our manufacturing
processes. It is responsible for the transfer of products from research
and development to manufacturing, product improvement, documentation,
metrology, and the quality assurance and regulatory compliance process.
Quality assurance represents a key element in our manufacturing
operations. Quality is assured through product testing at numerous
stages
in the manufacturing process to ensure that our products meet stringent
industry requirements and our customers’ performance
requirements.
|
·
|
Supply-Chain
Management. This department is responsible for
sales forecasting, raw material procurement, material-cost reduction
and
vendor performance management. Our products consist of optical, electronic
and mechanical parts, which are purchased from suppliers around the
world.
Approximately one-third of our parts are manufactured to our
specifications. Materials represent the biggest portion of our cost
of
goods and we relied more and more on outsourcing our manufacturing.
Our
performance is tightly linked to vendor performance, requiring greater
emphasis on this critical aspect of our
business.
|
·
|
product
performance and reliability;
|
·
|
price;
|
·
|
level
of technological innovation;
|
·
|
product
lead times;
|
·
|
breadth
of product offerings;
|
·
|
ease
of use;
|
·
|
brand-name
recognition;
|
·
|
customer
service and technical support;
|
·
|
strength
of sales and distribution relationships;
and
|
·
|
financial
stability.
|
·
|
a
method and apparatus for “non-intrusive” live-fiber detection and
monitoring, for which a PCT patent application has been
filed. This invention permits a fiber “clip-on” device to be
attached to a cabled fiber, essentially guaranteeing that the induced
bending loss to a live-traffic link will never exceed 1
dB. This is a key invention for our new LFD-250, LFD-300, and
TG-300 products, announced in September
2006.
|
·
|
the
measurement of attenuation of optical fibers using bidirectional
transmission of information via the fiber for which patents were
granted
in the United States and Canada. This invention forms the basis of
our
FOT-930 and FTB-3920 products;
|
·
|
a
method and apparatus for characterizing optical power levels in
three-wavelength, bidirectional fiber-to-the-home systems. This invention
describes how the optical power can be measured at the two-downstream
and
one upstream wavelengths used to connect a residence or business
customer,
while maintaining the signal continuity necessary to keep the home-based
Optical Network Terminal operating. A US patent and a German Utility
Model
have been granted, and a PCT patent application has been converted
to
national applications in a number of other countries. This invention
forms
the basis of the two-port version of our PPM-350B PON Power
Meter.
|
·
|
an
optical spectrum analyzer using optical fibers as input and output
“slits”. This invention forms the basis of our FTB-5240,
FTB-5240B and IQ-5250 products. A patent has been granted in the
US, UK,
Germany, France, and China, and an application is in process in
Canada.
|
·
|
a
light-curing system with closed-loop control and work-piece recording
which is at the heart of the spot-curing systems manufactured by
EXFO
Photonic Solutions and for which patents were granted in the United
States
and Canada;
|
·
|
a
special optical design used in some of the X-Cite adaptors to prevent
structure in the beam from reducing the uniformity of illumination
at the
microscope objective plane, which is a key patent for our X-Cite
fluorescent illumination system. A US patent has recently been
granted.
|
·
|
portable
test gear for TDM and packet-based communications for which patent
applications have been filed in Canada, the United States and pursuant
to
the Patent Cooperation Treaty form the basis of the technology used
by
EXFO Protocol for a number of its protocol testing
products.
|
·
|
a
method and apparatus to determine the theoretical and practical data
rates
for a cable under test. This invention forms the basis of the EXFO
CableSHARK product, describing how two test devices,
communicating with each other via the cable under test, can predict
the
performance of a pair of ADSL (Asymmetric Digital Subscriber Line)
modems,
and in case of problems, analyze the cause of the modems failing
to
synchronize. This patent has been granted in the US and in
Canada.
|
Location
|
Use
of Space
|
Square
Footage
|
Type
of Interest
|
436
Nolin Street
Quebec
(Quebec)
|
Partially
occupied for manufacturing of telecom products
|
44,164
(1)
|
Owned
|
400
Godin Avenue
Quebec
(Quebec)
|
Fully
occupied for research and development, manufacturing, management
and
administration
|
128,800
(2)
|
Owned
|
2260
Argentia Road
Mississauga
(Ontario)
|
Partially
occupied for research and development, manufacturing of life science
and
industrial products, management and
administration
|
25,328
(3)
|
Leased
|
2650
Marie-Curie St-Laurent (Quebec)
|
Fully
occupied for research and development, management and
administration
|
26,000
|
Leased
|
160
Drumlin Circle
Concord
(Ontario)
|
Partially
occupied for research and development, product management and
administration
|
23,500
(4)
|
Owned
|
1052
Vármegye utca 3-5 (Ausztria Ház)
Budapest,
Hungary
|
Research
and development, services (installation, training, support and
maintenance) and administration
|
2,500
|
Leased
|
Omega
Enterprise Park
Electron
Way, Chandlers Ford, Eastleigh, Hampshire S053 4SE
United
Kingdom
|
Partially
occupied for European customer service, sales management and
administration
|
10,000
|
Leased
|
Hua
Chuang Da Industrial Park
Bldg
D, 2/F, Hangcheng Blvd,
Gushu,
Xixiang
Shenzhen
518126
China
|
Partially
occupied for manufacturing of telecom products
|
40,000
(5)
|
Leased
|
113/1,
Lane 4A
Koregaon
Park
Pune
411 001
India
|
Fully
occupied for research and development
|
5,986
|
Leased
|
(1)
|
Approximately
10% of these premises are not
occupied.
|
(2)
|
Including
the warehousespace. Premises without the warehouse are approximately
115,000 square feet.
|
(3)
|
9,792
square feet have been subleased to a third party. The total square
footage
leased is 36,000.
|
(4)
|
Approximately
1/3 of these premises are not
occupied.
|
(5)
|
Approximately
20% of these premises are
occupied.
|
Management’s
Discussion and Analysis of Financial Condition and
Results of
Operations
|
Strategic
objectives for fiscal 2008
|
Key
performance indicators for fiscal 2008
|
Increase
sales through market-share gains
|
20%
sales growth year-over-year
|
Maximize
profitability
|
8%
in earnings from operations
|
Focus
on innovation
|
30%
of sales from new products (on the market two years or
less)
|
Consolidated
statements of earnings data:
|
2007
|
2006
|
|
2005
|
2007
|
2006
|
2005
|
|||||||||||||||||
Sales
|
$ |
152,934
|
$ |
128,253
|
$ |
97,216
|
100.0 | % | 100.0 | % | 100.0 | % | ||||||||||||
Cost
of sales (1)
|
65,136
|
57,275
|
44,059
|
42.6
|
44.7
|
45.3
|
||||||||||||||||||
Gross
margin
|
87,798
|
70,978
|
53,157
|
57.4
|
55.3
|
54.7
|
||||||||||||||||||
Operating
expenses
|
||||||||||||||||||||||||
Selling
and administrative
|
49,580
|
40,298
|
31,782
|
32.4
|
31.4
|
32.7
|
||||||||||||||||||
Net
research and development (2)
|
16,668
|
15,404
|
12,190
|
10.9
|
12.0
|
12.5
|
||||||||||||||||||
Amortization
of property, plant and equipment
|
2,983
|
3,523
|
4,256
|
1.9
|
2.7
|
4.4
|
||||||||||||||||||
Amortization
of intangible assets
|
2,864
|
4,394
|
4,836
|
1.9
|
3.4
|
5.0
|
||||||||||||||||||
Impairment
of long-lived assets
|
−
|
604
|
−
|
−
|
0.5
|
−
|
||||||||||||||||||
Government
grants
|
(1,079 | ) | (1,307 | ) |
−
|
(0.7 | ) | (1.0 | ) |
−
|
||||||||||||||
Restructuring
and other charges
|
−
|
−
|
292
|
−
|
−
|
0.3
|
||||||||||||||||||
Total
operating expenses
|
71,016
|
62,916
|
53,356
|
46.4
|
49.0
|
54.9
|
||||||||||||||||||
Earnings
(loss) from operations
|
16,782
|
8,062
|
(199 | ) |
11.0
|
6.3
|
(0.2 | ) | ||||||||||||||||
Interest
and other income
|
4,717
|
3,253
|
2,524
|
3.0
|
2.5
|
2.6
|
||||||||||||||||||
Foreign
exchange loss
|
(49 | ) | (595 | ) | (1,336 | ) |
−
|
(0.5 | ) | (1.4 | ) | |||||||||||||
Earnings
before income taxes
|
21,450
|
10,720
|
989
|
14.0
|
8.3
|
1.0
|
||||||||||||||||||
Income
taxes
|
||||||||||||||||||||||||
Current
|
3,741
|
2,585
|
2,623
|
2.4
|
2.0
|
2.7
|
||||||||||||||||||
Recognition
of previously unrecognized future income tax assets
|
(24,566 | ) |
−
|
−
|
(16.0 | ) |
−
|
−
|
||||||||||||||||
(20,825 | ) |
2,585
|
2,623
|
(13.6 | ) |
2.0
|
2.7
|
|||||||||||||||||
Net
earnings (loss) for the year
|
$ |
42,275
|
$ |
8,135
|
$ | (1,634 | ) | 27.6 | % | 6.3 | % | (1.7 | )% | |||||||||||
Basic
and diluted net earnings (loss) per share
|
$ |
0.61
|
$ |
0.12
|
$ | (0.02 | ) | |||||||||||||||||
Segment
information
|
||||||||||||||||||||||||
Sales:
|
||||||||||||||||||||||||
Telecom
Division
|
$ |
129,839
|
$ |
107,376
|
$ |
80,120
|
84.9 | % | 83.7 | % | 82.4 | % | ||||||||||||
Life
Sciences and Industrial Division
|
23,095
|
20,877
|
17,096
|
15.1
|
16.3
|
17.6
|
||||||||||||||||||
$ |
152,934
|
$ |
128,253
|
$ |
97,216
|
100.0 | % | 100.0 | % | 100.0 | % | |||||||||||||
Earnings
(loss) from operations:
|
||||||||||||||||||||||||
Telecom
Division
|
$ |
13,132
|
$ |
6,679
|
$ |
763
|
8.6 | % | 5.2 | % | 0.8 | % | ||||||||||||
Life
Sciences and Industrial Division
|
3,650
|
1,383
|
(962 | ) |
2.4
|
1.1
|
(1.0 | ) | ||||||||||||||||
$ |
16,782
|
$ |
8,062
|
$ | (199 | ) | 11.0 | % | 6.3 | % | (0.2 | )% | ||||||||||||
Research
and development data:
|
||||||||||||||||||||||||
Gross
research and development
|
$ |
25,201
|
$ |
19,488
|
$ |
15,878
|
16.5 | % | 15.2 | % | 16.3 | % | ||||||||||||
Net
research and development
(2)
|
$ |
16,668
|
$ |
15,404
|
$ |
12,190
|
10.9 | % | 12.0 | % | 12.5 | % | ||||||||||||
Consolidated
balance sheets data:
|
||||||||||||||||||||||||
Total
assets
|
$ |
279,138
|
$ |
219,159
|
$ |
190,957
|
(1)
The cost of sales is exclusive of amortization, shown
separately.
|
(2)
Net research and development expenses for the year ended August
31, 2007,
include recognition of previously unrecognized research and development
tax credits of $3,162.
|
Canada
|
||||||||||||
Year
of expiry
|
Federal
|
Provinces
|
United
States
|
|||||||||
2008
|
$ |
1,230,000
|
$ |
869,000
|
$ |
–
|
||||||
2009
|
2,845,000
|
162,000
|
–
|
|||||||||
2010
|
4,663,000
|
176,000
|
–
|
|||||||||
2014
|
93,000
|
2,000
|
–
|
|||||||||
2022
|
–
|
–
|
3,795,000
|
|||||||||
2023
|
–
|
–
|
1,671,000
|
|||||||||
Indefinite
|
–
|
–
|
7,474,000
|
|||||||||
$ |
8,831,000
|
$ |
1,209,000
|
$ |
12,940,000
|
Years
ending August 31,
|
2008
|
2009
|
2010
|
2011
|
2012
and
later
|
Total
|
||||||||||||||||||
Operating
leases
|
$ |
2,313,000
|
$ |
2,164,000
|
$ |
2,064,000
|
$ |
1,145,000
|
$ |
641,000
|
$ |
8,327,000
|
Expiry
dates:
|
Contractual
amounts
|
Weighted
average contractual forward rates
|
||||||
September
2007 to August 2008
|
$ |
36,900,000
|
1.1295
|
|||||
September
2008 to December 2009
|
15,400,000
|
1.1199
|
Stock
Options
|
Number
|
%
of issued and outstanding
|
Weighted
average exercise price
|
|||||||||
Chairman
of the Board, President and CEO (one
individual)
|
179,642
|
9 | % | $ |
9.05
|
|||||||
Board
of Directors (five individuals)
|
194,375
|
10 |
6.23
|
|||||||||
Management
and Corporate Officers (eight individuals)
|
212,139
|
11 |
14.49
|
|||||||||
586,156
|
30 | % | $ |
10.08
|
Restricted
Share Units (RSUs)
|
Number
|
%
of issued and outstanding
|
|
|||||||||
Chairman
of the Board, President and CEO (one
individual)
|
89,823
|
15 | % |
|
||||||||
Management
and Corporate Officers (ten individuals)
|
292,442
|
48 |
|
|||||||||
|
||||||||||||
382,265
|
63 | % |
Deferred
Share Units (DSUs)
|
Number
|
%
of issued and outstanding
|
|
|||||||||
Board
of Directors (five individuals)
|
70,195
|
100 | % |
|
Directors,
Senior Management and
Employees
|
Name
and Municipality of Residence
|
Positions
with EXFO
|
|
JON
BRADLEY
Worminghall,
United Kingdom
|
Vice-President,
Telecom Sales - International
|
|
STEPHEN
BULL
Quebec
City, Quebec
|
Vice-President,
Research and Development, Telecom Division
|
|
NORMAND
DUROCHER
St-Sauveur,
Quebec
|
Vice-President,
Human Resources
|
|
ALLAN
FIRHOJ
Georgestown,
Ontario
|
Vice-President
and General Manager, Life Sciences and Industrial
Division
|
|
ROBERT
FITTS
Minesing,
Ontario
|
Vice-President,
Corporate Development
|
|
ÉTIENNE
GAGNON
Quebec
City, Quebec
|
Vice-President,
Telecom Product Management and Marketing
|
|
LUC
GAGNON
St-Augustin-de-Desmaures,
Quebec
|
Vice-President,
Telecom Manufacturing Operations and Customer Service
|
|
GERMAIN
LAMONDE
St-Augustin-de-Desmaures,
Quebec
|
Chairman
of the Board, President and Chief Executive Officer
|
|
PIERRE
MARCOUILLER
Magog,
Quebec
|
Independent
Director
|
|
GUY
MARIER
Lakefield
Gore, Quebec
|
Independent
Lead Director
|
|
PIERRE
PLAMONDON, CA
Quebec
City, Quebec
|
Vice-President,
Finance and Chief Financial Officer
|
|
BENOIT
RINGUETTE
Quebec
City, Quebec
|
General
Counsel and Corporate Secretary
|
|
DAVID
A. THOMPSON
Newton,
North Carolina
|
Independent
Director
|
|
ANDRÉ
TREMBLAY
Outremont,
Quebec
|
Independent
Director
|
|
MICHAEL
UNGER
Richmond
Hill, Ontario
|
Independent
Director
|
|
DANA
YEARIAN
Lake
Forest, Illinois
|
Vice-President,
Telecom Sales - Americas
|
Annual
Retainer for Directors (1)
|
CA$50,000
|
(2)
|
US$44,583
(3)
|
Annual
Retainer for Lead Director
|
CA$5,000
|
US$4,458
(3)
|
|
Annual
Retainer for Committee Chairman
|
CA$5,000
|
US$4,458
(3)
|
|
Annual
Retainer for Committee Members
|
CA$3,000
|
US$2,675
(3)
|
|
Fees
for all Meetings Attended per day in Person
|
CA$1,000
|
US$892
(3)
|
|
Fees
for all Meetings Attended per day by Telephone
|
CA$500
|
US$446
(3)
|
(1)
|
All
the Directors elected to receive 50% of their Annual Retainer
in form of
Deferred Share Units except Mr. André Tremblay who elected to receive 100%
of his Annual Retainer in form of Deferred Share
Units.
|
(2)
|
The
Annual Retainer for Mr. David A. Thompson is US$50,000
(CA$56,075).
|
(3)
|
The
compensation information has been converted from Canadian
dollars to U.S.
dollars based upon an average foreign exchange rate of
CA$1.1215 = US$1.00
for 2007.
|
Name
|
Annual
Compensation Paid
in
Cash (US$) (1)
|
Annual
Compensation
Paid
in
DSUs (#) (2)
|
Estimated
Value of
DSUs
at the time of
grant
(US$) (3)
|
Total
Attendance
Fees
Paid in Cash
(US$) (1)
|
Pierre
Marcouiller (4)
|
27,642
|
3,586
|
22,292
|
4,012
|
Guy
Marier (5)
|
30,490
|
3,586
|
22,292
|
4,904
|
Dr.
David A. Thompson (6)
|
27,675
|
3,975
|
25,000
|
4,283
|
André
Tremblay (7)
|
7,133
|
7,172
|
44,583
|
5,796
|
Michael
Unger (8)
|
29,425
|
8,586(9)
|
53,544
|
5,796
|
(1)
|
The
compensation information has been converted from Canadian
dollars to U.S.
dollars based upon an average foreign exchange rate of
CA$1.1215 = US$1.00
for 2007 except for Mr. David A. Thompson who is paid in
U.S. dollar for
the portion of his annual retainer for Director. The Annual
Compensation includes, as the case may be, the retainer
for Director, Lead
Director, Committee Members and Committee
Chairman.
|
(2)
|
Indicates
the number of Subordinate Voting Shares granted under the
Deferred Share
Unit Plan. A DSU is converted in a Subordinate Voting Share when a
Director ceases to be a member of the
Board.
|
(3)
|
The
estimated value at the time of grant of a DSU is determined
based on the
highest of the closing prices of the Subordinate Voting
Shares on the
Toronto Stock Exchange and the NASDAQ National Market on
the last trading
day preceding the grant date, using the noon buying rate
of the Federal
Reserve Bank of New York on the grant date to convert the
NASDAQ National
Market closing price to Canadian dollars, as required.
The value at
vesting of a DSU is equivalent to the market value of a
Subordinate Voting
Share when a DSU is converted to such Subordinate Voting
Share.
|
(4)
|
Member
of the Audit Committee and the Human Resources
Committee.
|
(5)
|
Member
of the Audit Committee and the Human Resources Committee
and Lead
Director.
|
(6)
|
Member
of the Human Resources Committee.
|
(7)
|
Member
of the Human Resources Committee and Chairman of the Audit
Committee.
|
(8)
|
Member
of the Audit Committee and Chairman of the Human Resources
Committee.
|
(9)
|
Mr.
Unger received 5,000 DSUs in the financial year ended August
31, 2007 for
his past contribution as Lead
Director.
|
Name
and Principal
Position
|
Financial
Years
|
Salary
(1)
($)
|
Bonus
(2) ($)
|
Other
Annual Compensation ($) (3)
|
Securities
Under Options (4)
(#)
|
Restricted
Share Units (5) (#)
|
All
Other
Compensation
($)
|
Germain
Lamonde,
President
and Chief Executive Officer
|
2007
|
294,334 (US)
330,096 (CA)
|
131,145 (US)
147,080 (CA)
|
-
|
-
|
25,347
|
-
|
2006
|
271,753 (US)
312,000 (CA)
|
147,558 (US)
169,412 (CA)
|
-
|
11,218
|
21,477
|
-
|
|
2005
|
243,605 (US)
300,000 (CA)
|
121,729 (US)
149,909 (CA)
|
-
|
17,942
|
13,089
|
-
|
|
Pierre
Plamondon,
Vice-President
Finance and Chief Financial Officer
|
2007
|
173,862 (US)
194,986 (CA)
|
56,906 (US)
63,820 (CA)
|
-
|
-
|
12,930
|
4,836 (US) (6)
5,423 (CA)
|
2006
|
165,691 (US)
190,230 (CA)
|
60,167 (US)
69,078 (CA)
|
-
|
3,653
|
6,994
|
4,283 (US) (6)
4,918 (CA)
|
|
2005
|
151,441 (US)
186,500 (CA)
|
48,735 (US)
60,017 (CA)
|
-
|
5,383
|
33,927
|
2,316 (US) (6)
2,852 (CA)
|
Dana
Yearian,
Vice-President,
Telecom Sales - Americas
|
2007
|
250,592 (US)
281,039 (CA)
|
8,326 (US)
9,338 (CA)
|
-
|
-
|
6,645
|
566 (US) (6)
634 (CA)
|
2006
|
7,851 (US) (7)
9,014 (CA)
|
-
-
|
-
|
-
|
5,000
|
236 (US) (6)
270 (CA)
|
|
2005
|
-
-
|
-
-
|
-
|
-
|
-
|
-
|
|
Jon
Bradley,
Vice-President,
Telecom Sales - International
|
2007
|
226,991 (US)
254,571 (CA)
116,011 (£) (8)
|
19,470 (US)
21,836 (CA)
9,951 (£)
|
-
|
-
|
-
|
-
|
2006
|
194,908 (US)
223,774 (CA)
108,778
(£)
|
12,684 (US)
14,563 (CA)
7,079 (£)
|
-
|
-
|
2,500
|
-
|
|
2005
|
129,726 (US)
159,758 (CA)
70,258 (£)
|
13,400 (US)
16,502 (CA)
7,257 (£)
|
-
|
4,000
|
2,000
|
-
|
Name
and Principal
Position
|
Financial
Years
|
Salary
(1)
($)
|
Bonus
(2) ($)
|
Other
Annual Compensation ($) (3)
|
Securities
Under Options (4)
(#)
|
Restricted
Share Units (5) (#)
|
All
Other
Compensation
($)
|
Allan
Firhoj,
Vice-President
and General Manager, Life Sciences and Industrial Division
|
2007
|
148,373 (US) (9)
166,400 (CA)
|
58,969 (US)
66,133 (CA)
|
-
|
-
|
21,178
|
-
|
2006
|
139,361 (US)
160,000 (CA)
|
40,632 (US)
46,650 (CA)
|
-
|
2,404
|
4,602
|
-
|
|
2005
|
123,153 (US)
151,663 (CA)
|
18,355 (US)
22,604 (CA)
|
-
|
2,512
|
12,443
|
-
|
Named
Executive Officer Not in the Employ of the Corporation
at Year
End
|
Juan-Felipe
Gonzalez,
Vice-President,
Telecom Sales - International
|
2007
|
195,508 (US) (10)
219,262 (CA)
|
9,237 (US)
10,359 (CA)
|
-
|
-
|
-
|
-
|
2006
|
272,518 (US)
312,878 (CA)
|
12,891 (US)
14,800 (CA)
|
-
|
3,505
|
6,716
|
-
|
|
2005
|
246,323 (US)
303,347 (CA)
|
6,015 (US)
7,407 (CA)
|
-
|
5,482
|
33,998
|
-
|
(1)
|
The
compensation information for Canadian residents has been
converted from
Canadian dollars to U.S. dollars based upon an average
foreign exchange
rate of CA$1.1215 = US$1.00 for 2007, CA$1.1481 = US$1.00
for 2006 and
CA$1.2315 = US$1.00 for 2005. The currency conversions
cause these
reported salaries to fluctuate from year-to-year because
of the
fluctuation in exchange rate.
|
(2)
|
A
portion of the bonus amounts is paid in cash in the year
for which they
are awarded and the balance is paid in cash in the year
following the
financial year for which they are
awarded.
|
(3)
|
Indicates
only an aggregate amount if such amount is equivalent
or greater than
$50,000 and 10% of the total of the annual salary and
bonus of the Named
Executive Officer for the financial year ended August
31,
2007.
|
(4)
|
Indicates
the number of Subordinate Voting Shares underlying the
options granted
under the Long-Term Incentive Plan during the financial
year
indicated.
|
(5)
|
Indicates
the number of Restricted Share Units granted under the
Long-Term Incentive
Plan during the financial year
indicated.
|
(6)
|
Indicates
the amount contributed by the Corporation during the
financial year
indicated to the Deferred Profit Sharing Plan or 401K
Plan, as applicable,
for the benefit of the Named Executive Officer. Mr. Lamonde
is not
eligible to participate in the Deferred Profit Sharing
Plan and
Mr. Gonzalez did not
participate.
|
(7)
|
This
amount represents the salary paid to Mr. Yearian from
August 14, 2006
until August 31, 2006 which is based on an annual salary
amounted to
US$173,424 (CA$199,109) for the financial year ended
August 31,
2006.
|
(8)
|
The
compensation information for UK resident has been converted
from British
Pound to U.S. dollars based upon an average foreign exchange
rate of
£1.9566 = US$1.00 for 2007, £1.7918 = US$1.00 for 2006 and £1.8464 =
US$1.00 for 2005, for the conversion from U.S. dollars
to Canadian
dollars, please refer to note 1 above. The currency conversions
cause
these reported salaries to fluctuate from year-to-year
because of the
fluctuation in exchange rate.
|
(9)
|
Mr.
Firhoj also received an amount of US$690 (CA$615) for
untaken vacations
during the financial year ended August 31,
2007.
|
(10)
|
This
amount represents the salary paid to Mr. Gonzalez from
September 1st,
2006 until
March 1st,
2007 which
is based on an annual salary amounted to US$258,789 (CA$290,232)
for the
financial year ended August 31,
2007.
|
·
|
Performance-based:
Executive compensation levels reflect both corporation
and individual
results based on specific quantitative and qualitative
objectives
established at the start of each financial year in keeping
with
Corporation’s long-term strategic
objectives.
|
·
|
Aligned
with shareholder interests: A significant proportion of incentive
compensation for executives is composed of equity awards to ensure
that executives are aligned with the principles of sustained
long-term
shareholder value growth.
|
·
|
Market
competitive: Compensation of executives is designed to be
externally competitive when compared against executives
of comparable peer
companies, and in consideration of Corporation results
relative to the
results of peers.
|
·
|
Individually
equitable: Compensation levels are also designed to reflect
individual factors such as scope of responsibility, experience,
and
performance against individual
measures.
|
Measure
(1)
|
Weighting
Mr. Lamonde and Mr. Plamondon
|
Weighting
Mr. Firhoj
|
|
Corporate
objectives
|
|||
Sales
|
35%
|
30%
|
|
Earnings
|
15%
|
25%
|
|
Gross
margin
|
25%
|
25%
|
|
Customer
satisfaction (quality and on time delivery)
|
25%
|
20%
|
|
Total
|
0%
- 150%
|
0%
- 150%
|
|
Personal
objectives (multiplier)
|
0%
- 125%
|
0%
- 125%
|
|
Bonus
portion: corporate objectives (0% - 150%) x personal
objectives (0% -
125%)
|
Total
bonus portion
|
Total
bonus portion
|
(1)
|
Sales,
Earnings, Gross margin and Customer satisfaction measures
are established
to provide a metric from 0% to 150% and such a metric
is multiplied by the
personal objectives measure. This result is then multiplied
by the short
term incentive target % of the individual annual base
salary.
|
Number
of Options
|
%
of Issued and
Outstanding
Options
|
Weighted
Average Exercise Price ($US/Security)
|
||||||||||
President
and CEO (one individual)
|
179,642
|
9.31 | % |
9.05
|
||||||||
Board
of Directors (five individuals)
|
194,375
|
10.07 | % |
6.23
|
||||||||
Management
and Corporate Officers (eight individuals)
|
212,139
|
11.00 | % |
14.49
|
Number
of RSUs
|
%
of Issued and
Outstanding
RSUs
|
Weighted
Average Fair Value at the Time of Grant
$US/RSU
|
||||||||||
President
and CEO (one individual)
|
59,913
|
12.28 | % |
5.28
|
||||||||
Board
of Directors (five individuals)
|
-
|
-
|
-
|
|||||||||
Management
and Corporate Officers (ten individuals)
|
236,185
|
48.40 | % |
5.25
|
Name
|
Securities
Acquired on Exercise (#)
|
Aggregate
Value
Realized
(US$)
(1)
(4)
|
Unexercised
Options
at
August 31, 2007
|
Value
of Unexercised
“In-the-Money”
Options at
August
31, 2007 (2)
(3)
(4)
|
||
Exercisable
(#)
|
Unexercisable
(#)
|
Exercisable
(US$)
|
Unexercisable
(US$)
|
|||
Germain
Lamonde
|
-
|
-
|
162,258
|
17,384
|
233,041
|
24,996
|
Pierre
Plamondon
|
-
|
-
|
75,545
|
5,431
|
89,925
|
6,086
|
Dana
Yearian
|
-
|
-
|
-
|
-
|
-
|
-
|
Jon
Bradley
|
-
|
-
|
22,000
|
4,500
|
23,011
|
8,537
|
Allan
Firhoj
|
5,188
|
21,093
|
18,000
|
3,478
|
-
|
3,934
|
Named
Executive Officer Not in the Employ of the Corporation
at year
End
|
||||||
Juan-Felipe
Gonzalez
|
11,118
|
39,437
|
Cancelled
(5)
|
Cancelled
(5)
|
-
|
-
|
(1)
|
The
aggregate value realized is equivalent to the difference
between the
market value of the securities underlying the options
at exercise and the
exercise price of the options. This value, as the
case maybe, has been
converted from Canadian dollars to U.S. Dollars
based upon the average
foreign exchange rate on the day of the
exercise.
|
(2)
|
“In-the-money”
options are options for which the market value
of the underlying
securities is higher than the price at which such
securities may be bought
from the Corporation.
|
(3)
|
The
value of unexercisable “in-the-money” options is calculated using the
highest of the closing prices of the Subordinate
Voting Shares on the
Toronto Stock Exchange and on the NASDAQ National
Market on August 31,
2007 using the noon buying rate of the Federal
Reserve Bank of New York to
convert the NASDAQ National Market closing price
to Canadian dollars, as
required, less the exercise price of “in-the-money”
options.
|
(4)
|
This
value has been converted from Canadian to US dollars
based upon the
foreign exchange rate on August 31, 2007 of
1.056.
|
(5)
|
In
accordance with the terms of the Long-Term Incentive
Plan, unexercised
options that had been attributed to this person
were cancelled upon his
departure date.
|
Measure
(1)
|
Weighting
ALL
|
|
Corporate
objectives
|
||
Sales
|
35%
|
|
Earnings
|
15%
|
|
Gross
margin
|
25%
|
|
Customer
satisfaction (quality and on time delivery)
|
25%
|
|
Total
|
0%
- 150%
|
|
Personal
objectives (multiplier)
|
0%
- 125%
|
|
Bonus
portion: corporate objectives (0% - 150%) x personal objectives
(0% -
125%)
|
Total
bonus portion
|
(1)
|
Sales,
Earnings, Gross margin and Customer satisfaction measures
are established
to provide a metric from 0% to 150% and such a metric is
multiplied by the
personal objectives measure. This result is then multiplied
by the short
term incentive target % of the individual annual base
salary.
|
Number
of DSUs
|
%
of Issued and
Outstanding
DSUs
|
Weighted
Average Estimated Value at the Time of Grant
$US/DSU
|
|
Board
of Directors (five individuals)
|
70,195
|
100%
|
5.55
|
DSUs
#
|
Weighted
Average Estimated Value at the
Time
of Grant US$/DSU
|
Vesting
|
26,905
|
6.32
|
At
the time director cease to be a member of the Board of
the
Corporation
|
RSUs
#
|
Fair
Value at the Time of
Grant
US$/RSU
|
Vesting (1)
|
2,000
|
5.38
|
1/3
on each of the third, fourth and fifth anniversary dates
of the grant in
September 2006 (2)
|
1,200
|
5.83
|
50%
on the third and fourth anniversary dates of the grant
in September 2006
(3)
|
71,802
|
6.02
|
100%
on the fifth anniversary date of the grant in October 2011
subject to
early vesting up to 1/3 on the third anniversary date of
the grant and up
to 50% of the remaining units on the fourth anniversary
date of the grant
if the performance objectives are fully attained (4)
|
25,000
|
6.02
|
1/3
on each of the third, fourth and fifth anniversary dates
of the grant in
October 2006 (5)
|
22,550
|
6.42
|
1/3
on each of the third, fourth and fifth anniversary dates
of the grant in
January 2007 (6)
|
34,250
|
6.42
|
50%
on the third and fourth anniversary dates of the grant
in January
2007 (7)
|
60,200
|
7.32
|
50%
on the third and fourth anniversary dates of the grant
in January
2007 (7)
|
2,000
|
7.14
|
50%
on the third and fourth anniversary dates of the grant
in July
2007 (8)
|
(1)
|
All
RSUs first vesting cannot be earlier than the third anniversary
date of
their grant.
|
(2)
|
Those
RSUs granted in the financial year ended August 31, 2007
vest at a rate of
1/3 annually commencing on the third anniversary date of
the grant in
September 2006.
|
(3)
|
Those
RSUs granted in the financial year ended August 31, 2007
vest at a rate of
1/2 annually commencing on the third anniversary date of
the grant in
September 2006.
|
(4)
|
Those
RSUs granted in the financial year ended August 31, 2007
vest on the fifth
anniversary date of the grant in October 2011 but are subject to
early vesting on the third and fourth anniversary dates
of the grant on
the attainment of performance objectives, namely related to long term
growth of revenue and profitability, as determined by our
Board
of Directors. Accordingly, subject to the attainment of performance
objectives, the first early vesting is up to 1/3 of the units on the
third anniversary date of the grant and the second early
vesting is up to
50% of the remaining units on the fourth anniversary date
of the
grant.
|
(5)
|
Those
RSUs granted in the financial year ended August 31, 2007
vest at a rate of
1/3 annually commencing on the third anniversary date of
the grant in
October 2006.
|
(6)
|
Those
RSUs granted in the financial year ended August 31, 2007
vest at a rate of
1/3 annually commencing on the third anniversary date of
the grant in
January 2007.
|
(7)
|
Those
RSUs granted in the financial year ended August 31, 2007
vest at a rate of
1/2 annually commencing on the third anniversary date of
the grant in
January 2007.
|
(8)
|
Those
RSUs granted in the financial year ended August 31, 2007
vest at a rate of
1/2 annually commencing on the third anniversary date of
the grant in July
2007.
|
Name
|
RSUs
#
|
Percentage
of Net
Total
of RSUs
Granted
to Employees
in
Financial Year
(%)
|
Fair
Value at
the
Time of Grant US$/RSU
|
Vesting
(1)
|
Germain
Lamonde
|
25,347
|
11.57%
|
6.02
|
100%
on the fifth anniversary date of the grant in October 2006 subject to
early vesting up to 1/3 on the third anniversary date
of the grant and up
to 50% of the remaining units on the fourth anniversary
date of the grant
if the performance objectives are fully attained (2)
|
Pierre
Plamondon
|
8,430
|
3.85%
|
6.02
|
100%
on the fifth anniversary date of the grant in October 2006 subject to
early vesting up to 1/3 on the third anniversary date
of the grant and up
to 50% of the remaining units on the fourth anniversary
date of the grant
if the performance objectives are fully attained (2)
|
Pierre
Plamondon
|
4,500
|
2.05%
|
6.02
|
1/3
on each of third, fourth and fifth anniversary dates
of the grant in
October 2006 (3)
|
Dana
Yearian
|
6,645
|
3.03%
|
6.02
|
100%
on the fifth anniversary date of the grant in October 2006 subject to
early vesting up to 1/3 on the third anniversary date
of the grant and up
to 50% of the remaining units on the fourth anniversary
date of the grant
if the performance objectives are fully attained (2)
|
Jon
Bradley
|
−
|
−
|
−
|
−
|
Allan
Firhoj
|
6,145
|
2.81%
|
6.02
|
100%
on the fifth anniversary date of the grant in October 2006 subject to
early vesting up to 1/3 on the third anniversary date
of the grant and up
to 50% of the remaining units on the fourth anniversary
date of the grant
if the performance objectives are fully attained (2)
|
Allan
Firhoj
|
15,033
|
6.86%
|
6.42
|
1/3
on each of third, fourth and fifth anniversary dates
of the grant in
January 2007 (4)
|
Named
Executive Officer Not in the Employ of the Corporation
at year
End
|
Juan-Felipe
Gonzalez
|
−
|
−
|
−
|
−
|
(1)
|
All
RSUs first vesting cannot be earlier than the third
anniversary date of
their grant.
|
(2)
|
Those
RSUs granted in the financial year ended August 31,
2007 vest on the fifth
anniversary date of the grant in October 2006 but are subject to
early vesting on the third and fourth anniversary date
of the grant on the
attainment of performance objectives, namely related to long term
growth of revenue and profitability, as determined
by the Board
of Directors of the Corporation. Accordingly, subject
to the
attainment of performance objectives, the first early
vesting is up
to 1/3 of the units on the third anniversary date of
the grant and the
second early vesting is up to 50% of the remaining
units on the fourth
anniversary date of the grant.
|
(3)
|
Those
RSUs granted in the financial year ended August 31,
2007 vest at a rate of
1/3 annually commencing on the third anniversary date
of the grant in
October 2006.
|
(4)
|
Those
RSUs granted in the financial year ended August 31,
2007 vest at a rate of
1/3 annually commencing on the third anniversary date
of the grant in
January 2007.
|
Name
|
Securities
Acquired
on
Vesting (#)
|
Aggregate
Value Realized
(US$)
(1)
|
Unvested
RSUs
at
August 31, 2007 (#)
|
Value
of Unvested RSUs
at
August 31, 2007 (US$) (2)
(3)
|
Germain
Lamonde
|
-
|
-
|
59,913
|
401,417
|
Pierre
Plamondon
|
-
|
-
|
53,851
|
360,802
|
Dana
Yearian
|
-
|
-
|
11,645
|
78,022
|
Jon
Bradley
|
-
|
-
|
4,500
|
30,150
|
Allan
Firhoj
|
-
|
-
|
38,223
|
256,094
|
Named
Executive Officer Not in the Employ of the Corporation
at year
End
|
Juan-Felipe
Gonzalez
|
-
|
-
|
Cancelled (4)
|
Cancelled (4)
|
(1)
|
The
aggregate value realized is equivalent to the market value
of the
securities underlying the RSUs at vesting. This value,
as the case maybe,
has been converted from Canadian dollars to U.S. dollars
based upon the
average foreign exchange rate on the day of
vesting.
|
(2)
|
The
value of RSUs is calculated using the highest of the closing
prices of the
Subordinate Voting Shares on the Toronto Stock Exchange
and on the NASDAQ
National Market on August 31, 2007 using the noon buying
rate of the
Federal Reserve Bank of New York to convert the NASDAQ
National Market
closing price to Canadian dollars, as
required.
|
(3)
|
The
actual gains on vesting will depend on the value of the
Subordinate Voting
Shares on the date of vesting. There can be no assurance
that these values
will be realized.
|
(4)
|
In
accordance with the terms of the Long-Term Incentive Plan,
unvested RSUs
that had been attributed to this person were cancelled
upon his departure
date.
|
Name
and Position or Office
with
the Corporation
|
Principal
Occupation or
Employment
|
Residence
|
Director
Since
|
Number
of
Subordinate
Voting
Shares
|
Number
of
Multiple
Voting
Shares
|
Germain
Lamonde
Chairman
of the Board, President and Chief Executive Officer
|
Chairman
of the Board, President and Chief Executive Officer, EXFO
Electro-Optical
Engineering Inc.
|
St-Augustin-de-Desmaures,
Quebec,
Canada
|
September
1985
|
−
|
36,643,000
(1)
|
Pierre
Marcouiller (2)
(3)
Independent
Director
|
Chairman
of the Board and Chief Executive Officer,
Camoplast
Inc. (4)
|
Magog,
Quebec,
Canada
|
May
2000
|
5,000
|
−
|
Guy
Marier (2)
(3)
Independent
Lead Director
|
Executive
Consultant
|
Lakefield
Gore, Quebec,
Canada
|
January
2004
|
1,000
|
−
|
André
Tremblay (2)
(3)
Independent
Director
|
Founder
and Managing Partner, Trio Capital Inc., a private equity
fund
|
Outremont,
Quebec,
Canada
|
May
2000
|
6,650
(5)
|
−
|
Dr.
David A. Thompson, Ph.D.(3)
Independent
Director
|
Vice-President &
Director, Hardware & Equipment Technology, Corning Cable
Systems (6)
|
Newton,
North
Carolina,
USA
|
June
2000
|
2,100
|
−
|
Michael
Unger (2)
(3)
Independent
Director
|
Executive
Consultant
|
Richmond
Hill, Ontario,
Canada
|
May
2000
|
−
|
−
|
(1)
|
Mr.
Lamonde exercises control over this number of Multiple
Voting Shares
through G. Lamonde Investissements Financiers inc., a company
controlled by Mr. Lamonde and through Fiducie Germain Lamonde, a
family trust for the benefit of Mr. Lamonde’s
family.
|
(2)
|
Member
of the Audit Committee.
|
(3)
|
Member
of the Human Resources Committee.
|
(4)
|
Camoplast
Inc. designs, develops and manufactures specialized components,
sub-systems and assemblies for the world leading original
equipment
manufacturers (OEMs) of both on- and off-road vehicles
in a variety of
markets including automotive, agricultural, construction
and industrial,
defense and powersports.
|
(5)
|
Mr.
Tremblay exercises control over this number of Subordinate
Voting Shares
through 9104-5559 Quebec inc. a company controlled by Mr.
Tremblay.
|
(6)
|
Corning
Incorporated is a diversified technology company that concentrates
its
efforts on high-impact growth opportunities. Corning combines
its
expertise in specialty glass, ceramic materials, polymers
and the
manipulation of the properties of light, with strong process
and
manufacturing capabilities to develop, engineer and commercialize
significant innovative products for the telecommunications,
flat panel
display, environmental, semiconductor, and life sciences
industries.
|
Name
|
Subordinate
Voting
Shares
Owned
|
Currently
Exercisable Options Owned
as
of November 1, 2007
|
Total
Subordinate
Voting
Shares
Beneficially
Owned (3)
|
Multiple
Voting
Shares
Beneficially
Owned
(3)
|
Total
Percentage
of
Voting
Power
|
||||||
In-the-money
(1)
|
Out-the-money
(2)
|
||||||||||
Number
|
Percent
|
Number
|
Percent
|
Number
|
Percent
|
Number
|
Percent
|
Number
|
Percent
|
Percent
|
|
Germain
Lamonde (4)
|
–
|
*
|
61,776
|
*
|
100,482
|
*
|
162,258
|
*
|
36,643,000
|
100
|
91,9
|
Pierre
Plamondon
|
34,527 (5)
|
*
|
20,914
|
*
|
55,977
|
*
|
111,418
|
*
|
–
|
–
|
*
|
Pierre
Marcouiller
|
5,000
|
*
|
25,000
|
*
|
23,882
|
*
|
53,882
|
*
|
–
|
–
|
*
|
Guy
Marier
|
1,000
|
*
|
–
|
*
|
9,375
|
*
|
10,375
|
*
|
–
|
–
|
*
|
David
A. Thompson
|
2,100
|
*
|
25,000
|
*
|
17,734
|
*
|
44,834
|
*
|
–
|
–
|
*
|
André
Tremblay
|
6,650 (6)
|
*
|
25,000
|
*
|
19,691
|
*
|
51,341
|
*
|
–
|
–
|
*
|
Michael
Unger
|
–
|
*
|
25,000
|
*
|
20,568
|
*
|
45,568
|
*
|
–
|
–
|
*
|
Dana
Yearian
|
–
|
*
|
–
|
*
|
–
|
*
|
–
|
*
|
–
|
–
|
*
|
Jon
Bradley
|
–
|
*
|
11,000
|
*
|
11,000
|
*
|
22,000
|
*
|
–
|
–
|
*
|
Allan
Firhoj
|
–
|
*
|
0
|
*
|
18,837
|
*
|
18,837
|
*
|
–
|
–
|
*
|
Other
executive officers as a group
|
35,025
|
*
|
22,181
|
*
|
50,365
|
*
|
107,571
|
*
|
–
|
–
|
*
|
All
of our Directors and executive officers as a group
|
84,302
|
*
|
215,871
|
*
|
327,911
|
*
|
628,084
|
*
|
36,643,000
|
100
|
92.0
|
Named
Executive Officer Not in the Employ of the Corporation at year
End
|
|||||||||||
Juan-Felipe
Gonzalez
|
–
|
*
|
–
|
*
|
–
|
*
|
–
|
*
|
–
|
–
|
*
|
*
|
Less
than 1%.
|
(1)
|
“In-the-money”
options are options for which the market value of the underlying
securities is higher than the price at which such securities
may be bought
from the Corporation. As of November 1, 2007 the market value
of a
Subordinate Voting Share was
US$6.35.
|
(2)
|
“Out-the-money”
options are options for which the market value of the underlying
securities is lower than the price of which such securities
may be bought
from the Corporation.
|
(3)
|
Beneficial
ownership is determined in accordance with the rules of the
SEC and
generally includes voting or investment power with respect
to securities.
Options that are currently exercisable (including options that
have an
exercise price above the market price) are deemed to be outstanding
and to
be beneficially owned by the person holding such options for
the purpose
of computing the percentage ownership of such person, but are
not treated
as outstanding for the purpose of computing the percentage
ownership of
any other person. Accordingly, DSUs and RSUs are not
included.
|
(4)
|
The
number of shares held by Germain Lamonde includes 1,900,000
multiple
voting shares held of record by Fiducie Germain Lamonde and
34,743,000
multiple voting shares held of record by G. Lamonde Investissements
Financiers inc.
|
(5)
|
The
number of shares held by Pierre Plamondon includes 6,874 subordinate
voting shares held of record by Fiducie Pierre
Plamondon.
|
(6)
|
The
number of subordinate voting shares held of record by André Tremblay is
held by 9104-5559 Québec Inc, a company controlled by Mr.
Tremblay.
|
Name
|
Securities
Under Options
Granted
(1)
(#)
|
Exercise
Price (2)
(US$/Security)
|
Expiration
Date
|
Germain
Lamonde
|
25,402
5,080
70,000
50,000
17,942
11,218
|
$26.00
$22.25
$9.13
$1.58
$4.51
$4.76
|
June
29, 2010
January
10, 2011
October
10, 2011
September
25, 2012
February
1, 2015
December
6, 2015
|
Pierre
Plamondon
|
8,700
10,000
5,000
9,240
19,000
20,000
5,383
3,653
|
$26.00
$45.94
$34.07
$22.25
$9.13
$1.58
$5.13
$4.76
|
June
29, 2010
September
13, 2010
October
11, 2010
January
10, 2011
October
10, 2011
September
25, 2012
October
26, 2014
December
6, 2015
|
Pierre
Marcouiller
|
2,000
400
17,966
1,037
2,479
12,500
12,500
|
$26.00
$22.25
$9.13
$12.69
$5.65
$1.58
$3.51
|
June
29, 2010
January
10, 2011
October
10, 2011
December
1, 2011
March
1, 2012
September
25, 2012
October
27, 2013
|
Guy
Marier
|
12,500
|
$4.65
|
March
24, 2014
|
David
A. Thompson
|
2,000
400
15,334
12,500
12,500
|
$26.00
$22.25
$9.13
$1.58
$3.51
|
June
29, 2010
January
10, 2011
October
10, 2011
September
25, 2012
October
27, 2013
|
André
Tremblay
|
2,000
400
17,291
12,500
12,500
|
$26.00
$22.25
$9.13
$1.58
$3.51
|
June
29, 2010
January
10, 2011
October
10, 2011
September
25, 2012
October
27, 2013
|
Michael
Unger
|
2,000
400
18,168
12,500
12,500
|
$26.00
$22.25
$9.13
$1.58
$3.51
|
June
29, 2010
January
10, 2011
October
10, 2011
September
25, 2012
October
27, 2013
|
Dana
Yearian
|
−
|
−
|
−
|
Jon
Bradley
|
5,000
5,000
1,000
1,500
10,000
4,000
|
$45.94
$22.25
$12.22
$3.19
$3.50
$4.51
|
September
13, 2010
January
10, 2011
January
3, 2012
January
7, 2013
December
17, 2013
February
1, 2015
|
Allan
Firhoj
|
10,000
8,000
1,675
1,803
|
$23.40
$9.13
$5.13
$4.76
|
March
15, 2011
October
10, 2011
October
26, 2014
December
6, 2015
|
Name
|
Securities
Under Options
Granted
(1)
(#)
|
Exercise
Price (2)
(US$/Security)
|
Expiration
Date
|
Other
Executive Officers as a group
|
900
8,000
4,000
6,180
25,000
15,000
5,000
9,379
2,000
7,726
|
$26.00
$45.94
$34.07
$22.25
$9.13
$1.58
$3.19
$5.13
$4.51
$4.76
|
June
29, 2010
September
13, 2010
October
11, 2010
January
10, 2011
October
10, 2011
September
25, 2012
January
7, 2013
October
26, 2014
February
1, 2015
December
6, 2015
|
Named
Executive Officer Not in the Employ of the Corporation at year
End
|
|||
Juan
Felipe Gonzalez
|
−
|
−
|
−
|
____________________________ | |||
(1)
|
Underlying
securities: subordinate voting
shares
|
(2)
|
The
exercise price of options granted is determined based on the
highest of
the closing prices of the subordinate voting shares on the
Toronto Stock
Exchange and the NASDAQ National Market on the last trading
day preceding
the grant date, using the noon buying rate of the Federal Reserve
Bank of
New York on the grant date to convert the NASDAQ National Market
closing
price to Canadian dollars, as
required.
|
Name
|
DSUs
|
RSUs
|
||||
Number
|
Percentage
|
Estimated
Average
Value
at the time of
grant
US$/DSU (1)
|
Number
|
Percentage
|
Fair
Value at the
time
of grant
US$/RSU
(2)
|
|
Germain
Lamonde
|
–
|
–
|
–
|
13,089 (3)
|
2.2%
|
4.69
|
–
|
–
|
–
|
21,477 (4)
|
3.6%
|
4.76
|
|
–
|
–
|
–
|
25,347 (5)
|
4.2%
|
6.02
|
|
–
|
–
|
–
|
29,910 (6)
|
5.0%
|
6.28
|
|
Pierre
Plamondon
|
–
|
–
|
–
|
3,927 (3)
|
0.7%
|
4.69
|
–
|
–
|
–
|
30,000 (7)
|
5.0%
|
4.69
|
|
–
|
–
|
–
|
6,994 (4)
|
1.2%
|
4.76
|
|
–
|
–
|
–
|
8,430 (5)
|
1.4%
|
6.02
|
|
–
|
–
|
–
|
4,500 (8)
|
0.8%
|
6.02
|
|
–
|
–
|
–
|
9,637 (6)
|
1.6%
|
6.28
|
|
Pierre
Marcouiller
|
11,935 (9)
|
17.0%
|
5.55
|
–
|
–
|
–
|
Guy
Marier
|
11,935 (9)
|
17.0%
|
5.55
|
–
|
–
|
–
|
David
A. Thompson
|
13,869 (9)
|
19.8%
|
5.55
|
–
|
–
|
–
|
André
Tremblay
|
15,521 (9)
|
22.1%
|
5.55
|
–
|
–
|
–
|
Michael
Unger
|
16,935 (9)
|
24.1%
|
5.55
|
–
|
–
|
–
|
Dana
Yearian
|
–
|
–
|
–
|
5,000 (10)
|
0.8%
|
5.16
|
–
|
–
|
–
|
6,645 (5)
|
1.1%
|
6.02
|
|
–
|
–
|
–
|
7,225 (6)
|
1.2%
|
6.28
|
|
Jon
Bradley
|
–
|
–
|
–
|
2,000 (11)
|
0.3%
|
4.51
|
–
|
–
|
–
|
2,500 (12)
|
0.4%
|
5.59
|
|
–
|
–
|
–
|
6,122 (6)
|
1.0%
|
6.28
|
|
Allan
Firhoj
|
–
|
–
|
–
|
2,443 (3)
|
0.4%
|
4.69
|
–
|
–
|
–
|
10,000 (7)
|
1.7%
|
4.69
|
|
–
|
–
|
–
|
4,602 (4)
|
0.7%
|
4.76
|
|
–
|
–
|
–
|
6,145 (5)
|
1.0%
|
6.02
|
|
–
|
–
|
–
|
15,033 (13)
|
2.5%
|
6.42
|
|
–
|
–
|
–
|
7,676 (6)
|
1.3%
|
6.28
|
Name
|
DSUs
|
RSUs
|
|||||
Number
|
Percentage
|
Estimated
Average
Value
at the time of
grant
US$/DSU (1)
|
Number
|
Percentage
|
Fair
Value at the
time
of grant
US$/RSU
(2)
|
||
Other
executive officers as a group
|
–
|
–
|
–
|
9,023 (3)
|
1.5%
|
4.69
|
|
–
|
–
|
–
|
51,500 (7)
|
8.5%
|
4.69
|
||
–
|
–
|
–
|
16,708 (4)
|
2.8%
|
4.76
|
||
–
|
–
|
–
|
3,250 (12)
|
0.5%
|
5.59
|
||
–
|
–
|
–
|
25,235 (5)
|
4.2%
|
6.02
|
||
–
|
–
|
–
|
20,500 (8)
|
3.4%
|
6.02
|
||
–
|
–
|
–
|
1,750 (13)
|
0.3%
|
6.42
|
||
–
|
–
|
–
|
25,597 (6)
|
4.2%
|
6.28
|
||
All
of the directors and executive officers as a group
|
–
|
–
|
–
|
28,842 (3)
|
4.7%
|
4.69
|
|
–
|
–
|
–
|
91,500 (7)
|
15.2%
|
4.69
|
||
–
|
–
|
–
|
2,000 (11)
|
0.3%
|
4.51
|
||
–
|
–
|
–
|
49,781 (4)
|
8.3%
|
4.76
|
||
–
|
–
|
–
|
5,750 (12)
|
1.0%
|
5.59
|
||
–
|
–
|
–
|
5,000 (10)
|
0.8%
|
5.16
|
||
–
|
–
|
–
|
71,802 (5)
|
7.7%
|
6.02
|
||
–
|
–
|
–
|
25,000 (8)
|
4.1%
|
6.02
|
||
–
|
–
|
–
|
16,783 (13)
|
2.8%
|
6.42
|
||
–
|
–
|
–
|
86,167 (6)
|
14.3%
|
6.28
|
||
70,195
|
100%
|
5.55
|
382,265
|
||||
Named
Executive Officer Not in the Employ of the Corporation at year
End
|
|||||||
Juan-Felipe
Gonzalez
|
–
|
–
|
–
|
Cancelled (14)
|
−
|
−
|
|
__________________________ | |||||||
(1)
|
The
estimated average value at the time of grant of a DSU is
the average of
the estimated value at the time of grant of a DSU which is
determined
based on the highest of the closing prices of the Subordinate
Voting
Shares on the Toronto Stock Exchange and the NASDAQ National
Market on the
last trading day preceding the grant date, using the noon
buying rate of
the Federal Reserve Bank of New York on the grant date to
convert the
NASDAQ National Market closing price to Canadian dollars,
as required. The
value at vesting of a DSU is equivalent to the market value
of a
Subordinate Voting Share when a DSU is converted to such
Subordinate
Voting Share.
|
(2)
|
The
fair value at the time of grant of a RSU is equal to the market
value of
Subordinate Voting Shares at the time RSUs are
granted.
|
(3)
|
Those
RSUs will vest on the fifth anniversary date of the grant in
January 2005
but are subject to early vesting on the third and fourth anniversary
date
of the grant on the attainment of performance objectives as
determined by
the Board of Directors. Accordingly, subject to the attainment
of
performance objectives, the first early vesting is up to 1/3
of the units
on the third anniversary date of the grant and the second early
vesting is
up to 50% of the remaining units on the fourth anniversary
date of the
grant.
|
(4)
|
Those
RSUs will vest on the fifth anniversary date of the grant in
December 2005
but are subject to early vesting on the third and fourth anniversary
date
of the grant on the attainment of performance objectives as
determined by
the Board of Directors. Accordingly, subject to the attainment
of
performance objectives, the first early vesting is up to 1/3
of the units
on the third anniversary date of the grant and the second early
vesting is
up to 50% of the remaining units on the fourth anniversary
date of the
grant.
|
(5)
|
Those
RSUs will vest on the fifth anniversary date of the grant in
October 2006
but are subject to early vesting on the third and fourth anniversary
date
of the grant on the attainment of performance objectives as
determined by
the Board of Directors. Accordingly, subject to the attainment
of
performance objectives, the first early vesting is up to 1/3
of the units
on the third anniversary date of the grant and the second early
vesting is
up to 50% of the remaining units on the fourth anniversary
date of the
grant.
|
(6)
|
Those
RSUs will vest on the fifth anniversary date of the grant in
October 2007
but are subject to early vesting on the third and fourth anniversary
date
of the grant on the attainment of performance objectives as
determined by
the Board of Directors. Accordingly, subject to the attainment
of
performance objectives, the first early vesting is up to 1/3
of the units
on the third anniversary date of the grant and the second early
vesting is
up to 50% of the remaining units on the fourth anniversary
date of the
grant.
|
(7)
|
Those
RSUs will vest at a rate of 55%, 35% and 10%, on the third,
fourth and
fifth anniversary dates of the grant in
January 2005.
|
(8)
|
Those
RSUs will vest at a rate of 1/3 annually commencing on the
third
anniversary date of the grant in
October 2006.
|
(9)
|
Those
DSUs will vest at the time Director cease to be a member of
the Board of
the Corporation.
|
(10)
|
Those
RSUs will vest at a rate of 1/3 annually commencing on the
third
anniversary date of the grant in August
2006.
|
(11)
|
Those
RSUs will vest at a rate of 1/3 annually commencing on the
third
anniversary date of the grant in February
2005.
|
(12)
|
Those
RSUs will vest at a rate of 1/2 annually commencing on the
third
anniversary date of the grant in
February 2006.
|
(13)
|
Those
RSUs will vest at a rate of 1/3 annually commencing on the
third
anniversary date of the grant in January
2007.
|
(14)
|
In
accordance with the terms of the Long-Term Incentive Plan,
unvested RSUs
that had been attributed to this person were cancelled upon
his departure
date.
|
Designation
of Class
|
Number
of Securities held in escrow
|
Percentage
of Class
|
||
Subordinate
Voting Shares
|
nil
|
nil
|
||
Multiple
Voting Shares
|
nil
|
nil
|
Multiple
Voting Shares
Beneficially
Owned (1)
|
Subordinate
Voting Shares
Beneficially
Owned (1)
|
Total
Percentage of
Voting
Power
|
|||
Name
|
Number
|
Percent
|
Number
|
Percent
|
Percent
|
Germain
Lamonde (2)
|
36,643,000
|
100%
|
Nil
|
Nil
|
91.89%
|
Fiducie
Germain Lamonde (3)
|
1,900,000
|
5%
|
Nil
|
Nil
|
4.76%
|
G.
Lamonde Investissements Financiers inc. (4)
|
34,743,000
|
95%
|
Nil
|
Nil
|
87.13%
|
Pyramis
Global Advisors, LLC (5)
|
Nil
|
Nil
|
3,576,400
|
11.05%
|
*
|
Kern
Capital Management, LLC (6)
|
Nil
|
Nil
|
1,855,113
|
5.73%
|
*
|
*
|
Less
than 1%
|
(1)
|
Beneficial
ownership is determined in accordance with the rules of the
SEC and
generally includes voting or investment power with respect
to securities.
Options that are currently exercisable (including options
that have an
exercise price above the market price) are deemed to be outstanding
and to
be beneficially owned by the person holding such options
for the purpose
of computing the percentage ownership of such person, but
are not treated
as outstanding for the purpose of computing the percentage
ownership of
any other person.
|
(2)
|
The
number of shares held by Germain Lamonde includes 1,900,000
multiple
voting shares held of record by Fiducie Germain Lamonde and
34,743,000
multiple voting shares held of record by G. Lamonde Investissements
Financiers inc.
|
(3)
|
Fiducie
Germain Lamonde is a family trust for the benefit of Mr.
Lamonde and
members of his family.
|
(4)
|
G.
Lamonde Investissements Financiers inc. is a company controlled
by Mr.
Lamonde.
|
(5)
|
As
of September 30, 2007, Pyramis Global Advisors, LLC, an indirect
wholly-owned subsidiary of FMR Corporation (Fidelity Management
and
Research Company), is the beneficial owner of this number
of subordinate
voting shares as a result of acting as investment advisor
to various
investment companies.
|
(6)
|
As
of September 30, 2007, Kern Capital Management LLC controls
the voting
rights attached to this number of subordinate voting shares
through
relationships with several clients and does not beneficially
own directly
this number of subordinate voting
shares.
|
Location
|
Square
Footage
|
Annual
Rent
|
Expiry
Date
|
465
Godin
|
24,000
|
CA$144,000
|
November
30, 2006
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Balance
– Beginning of year
|
$ |
451
|
$ |
352
|
$ |
510
|
||||||
Addition
charged to earnings
|
42
|
115
|
329
|
|||||||||
Write-offs
of uncollectible accounts
|
(271 | ) | (123 | ) | (23 | ) | ||||||
Recovery
of uncollectible accounts
|
(16 | ) | (111 | ) | (464 | ) | ||||||
Business
combination
|
−
|
218
|
−
|
|||||||||
Balance
– End of year
|
$ |
206
|
$ |
451
|
$ |
352
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Balance
– Beginning of year
|
$ |
38,543
|
$ |
38,406
|
$ |
32,613
|
||||||
Change
in valuation allowance
|
(28,646 | ) | (1,877 | ) |
3,375
|
|||||||
Foreign
currency translation adjustment
|
2,595
|
2,014
|
2,418
|
|||||||||
Balance
– End of year
|
$ |
12,492
|
$ |
38,543
|
$ |
38,406
|
Years
ended August 31,
|
||||||||||||||||||||||||
2007
|
2006
|
2005
|
||||||||||||||||||||||
Export
Sales
|
$ |
143,315
|
94 | % | $ |
119,486
|
93 | % | $ |
90,386
|
92 | % | ||||||||||||
Domestic
Sales
|
$ |
9,619
|
6
|
$ |
8,767
|
7
|
$ |
6,830
|
8
|
|||||||||||||||
$ |
152,934
|
100 | % | $ |
128,253
|
100 | % | $ |
97,216
|
100 | % |
NASDAQ
(US$)
|
TSX (CA$)
|
|||||||||||||||
High
|
Low
|
High
|
Low
|
|||||||||||||
September
1, 2002 to August 31, 2003
|
3.63
|
1.40
|
5.60
|
2.30
|
||||||||||||
September
1, 2003 to August 31, 2004
|
7.09
|
2.71
|
9.15
|
3.75
|
||||||||||||
September
1, 2004 to August 31, 2005
|
5.51
|
3.92
|
6.90
|
4.92
|
||||||||||||
September
1, 2005 to August 31, 2006
|
8.69
|
4.32
|
9.60
|
5.15
|
||||||||||||
September
1, 2006 to August 31, 2007
|
7.57
|
4.89
|
8.85
|
5.55
|
||||||||||||
2006
1st Quarter
|
5.05
|
4.32
|
5.92
|
5.15
|
||||||||||||
2006
2nd Quarter
|
6.70
|
4.39
|
7.64
|
5.16
|
||||||||||||
2006
3rd Quarter
|
8.69
|
6.44
|
9.60
|
7.18
|
||||||||||||
2006
4th Quarter
|
7.01
|
4.86
|
7.80
|
5.45
|
||||||||||||
2007
1st Quarter
|
6.13
|
4.89
|
6.90
|
5.55
|
||||||||||||
2007
2nd Quarter
|
7.48
|
5.21
|
8.85
|
6.05
|
||||||||||||
2007
3rd Quarter
|
6.94
|
5.92
|
7.82
|
6.70
|
||||||||||||
2007
4th Quarter
|
7.57
|
5.94
|
7.95
|
6.42
|
||||||||||||
2007
May
|
6.65
|
6.01
|
7.23
|
6.70
|
||||||||||||
2007
June
|
7.03
|
6.60
|
7.60
|
7.07
|
||||||||||||
2007
July
|
7.57
|
6.83
|
7.95
|
7.47
|
||||||||||||
2007
August
|
7.55
|
5.94
|
7.93
|
6.42
|
||||||||||||
2007
September
|
7.28
|
6.61
|
7.35
|
6.62
|
||||||||||||
2007
October
|
7.07
|
6.17
|
6.92
|
5.93
|
||||||||||||
2007
November
|
6.41
|
5.86
|
6.05
|
5.56
|
||||||||||||
(until
November 12)
|
|
(a)
|
an
individual citizen or resident of the United
States;
|
|
(b)
|
a
corporation created or organized under the laws of the United
States or
any state thereof and the District of
Columbia;
|
|
(c)
|
an
estate the income of which is subject to United States federal
income
taxation regardless of its source;
|
|
(d)
|
a
trust if (1) a court within the United States is able to
exercise primary
jurisdiction over its administration and one or more U.S.
persons as
described in Section 7701 (a) (30) of the Code have authority
to control
all substantial decisions of the trust or (2) the trust has
a valid
election in effect under applicable U.S. Treasury regulations
to be
treated as a U.S. person; or
|
|
(e)
|
any
other person whose worldwide income or gain is otherwise
subject to U.S.
federal income taxation on a net income
basis;
|
·
|
the
Code;
|
·
|
U.S.
judicial decisions;
|
·
|
administrative
pronouncements;
|
·
|
existing
and proposed Treasury regulations;
and
|
·
|
the
Canada – U.S. Income Tax Treaty.
|
·
|
the
holder’s holding period for the subordinate voting shares, with
a
preferential rate available for subordinate voting shares
held for more
than one year; and
|
·
|
the
holder’s marginal tax rate for ordinary
income.
|
·
|
such
gain is effectively connected with the conduct by such Non-U.S.
Holder of
a trade or business in the United States;
or
|
·
|
in
the case of any gain realized by an individual Non-U.S. Holder,
such
Non-U.S. Holder is present in the United States for 183 days or more
in the taxable year of such sale and certain other conditions
are
met.
|
·
|
at
least 75% of our gross income for the taxable year is passive
income;
or
|
·
|
at
least 50% of the average value of our assets is attributable
to assets
that produce or are held for the production of passive
income.
|
·
|
dividends;
|
·
|
interest;
|
·
|
rents
or royalties, other than certain rents or royalties derived
from the
active conduct of trade or
business;
|
·
|
annuities;
or
|
·
|
gains
from assets that produce passive
income.
|
·
|
any
gain realized on the sale or other disposition of subordinate
voting
shares; and
|
·
|
any
“excess distribution” by us to the U.S.
Holder.
|
·
|
the
gain or excess distribution would be allocated ratably over
the U.S.
Holder’s holding period for the subordinate voting
shares;
|
·
|
the
amount allocated to the taxable year in which the gain or
excess
distribution was realized would be taxable as ordinary
income;
|
·
|
the
amount allocated to each prior year, with certain exceptions,
would be
subject to tax at the highest tax rate in effect for that
year;
and
|
·
|
the
interest charge generally applicable to underpayments of
tax would be
imposed in respect of the tax attributable to each such
year.
|
·
|
is
resident in the United States and not resident in
Canada,
|
·
|
holds
the subordinate voting shares as capital
property,
|
·
|
does
not have a “permanent establishment” or “fixed base” in Canada, as defined
in the Convention; and
|
·
|
deals
at arm’s length with us. Special rules, which are not discussed
below, may
apply to “financial institutions”, as defined in the ITA, and to
non-resident insurers carrying on an insurance business in
Canada and
elsewhere.
|
Years
ending August 31,
|
||||||||||||
2008
|
2009
|
2010
|
||||||||||
Forward
exchange contracts to sell US dollars in exchange for Canadian
dollars
Contractual
amounts
|
$ |
36,900
|
$ |
14,200
|
$ |
1,200
|
||||||
Weighted
average contractual exchange rates
|
1.1295
|
1.1180
|
1.1425
|
1
|
Our
consolidated financial
statements are prepared in accordance with generally accepted
accounting
principles in Canada (“Canadian GAAP”) and significant differences in
measurement and disclosure from generally accepted accounting
principles
in United States (“U.S. GAAP”) are set out in note 20 to our consolidated
financial statements included elsewhere in this annual
report.
|
·
|
Board
of Directors Corporate Governance
Guidelines;
|
·
|
Code
of Ethics for our Principal Executive Officer and Senior
Financial
Officers;
|
·
|
Ethics
and Business Conduct Policy;
|
·
|
Statement
of Reporting Ethical Violations (Whistle
Blower).
|
Number
|
Exhibit
|
1.1
|
Amended
Articles of Incorporation of EXFO (incorporated by reference
to Exhibit
3.1 of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File No. 333-38956).
|
1.2
|
Amended
By-laws of EXFO (incorporated by reference to Exhibit 1.2
of EXFO’s annual
report on Form-20F dated January 15, 2003, File No.
000-30895).
|
1.3
|
Amended
and Restated Articles of Incorporation of EXFO (incorporated
by reference
to Exhibit 1.3 of EXFO’s annual report on Form 20-F dated January 18,
2001, File No. 000-30895).
|
2.1
|
Form
of Subordinate Voting Share Certificate (incorporated by
reference to
Exhibit 4.1 of EXFO’s Registration Statement on Form F-1 filed on June 9,
2000, File No. 333-38956).
|
2.2
|
Form
of Registration Rights Agreement between EXFO and Germain
Lamonde dated
July 6, 2000 ) (incorporated by reference to Exhibit 10.13 of
EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File No.
333-38956).
|
3.1
|
Form
of Trust Agreement among EXFO, Germain Lamonde, GEXFO Investissements
Technologiques inc., Fiducie Germain Lamonde and G. Lamonde
Investissements Financiers inc. (incorporated by reference
to Exhibit
4.2 of EXFO’s Registration Statement on Form F-1 filed on June
9, 2000, File No. 333-38956).
|
4.1
|
Agreement
of Merger and Plan of Reorganization, dated as of November
4, 2000, by and
among EXFO, EXFO Sub, Inc., EXFO Burleigh Instruments, Inc.,
Robert G.
Klimasewski, William G. May, Jr., David J. Farrell and William
S. Gornall
(incorporated by reference to Exhibit 4.1 of EXFO’s annual report on Form
20-F dated January 18, 2001, File No. 000-30895).
|
4.2
|
Amendment
No. 1 to Agreement of Merger and Plan of Agreement, dated
as of December
20, 2000, by and among EXFO, EXFO Sub, Inc., EXFO Burleigh
Instruments,
Inc., Robert G. Klimasewski, William G. May, Jr., David J.
Farrell and
William S. Gornall (incorporated by reference to Exhibit
4.2 of EXFO’s
annual report on Form 20-F dated January 18, 2001, File No.
000-30895).
|
4.3
|
Agreement
of Merger, dated as of August 20, 2001, by and among EXFO,
Buyer Sub, and
Avantas Networks Corporation and Shareholders of Avantas
Networks
corporation (incorporated by reference to Exhibit 4.3 of
EXFO’s annual
report on Form 20-F dated January 18, 2002, File No.
000-30895).
|
4.4
|
Amendment
No. 1 dated as of November 1, 2002 to Agreement of Merger,
dated as of
August 20, 2001, by and among EXFO, 3905268 Canada Inc.,
Avantas Networks
Corporation and Shareholders of Avantas Networks (incorporated
by
reference to Exhibit 4.4 of EXFO’s annual report on Form 20-F dated
January 18, 2002, File No. 000-30895).
|
4.5
|
Offer
to purchase shares of Nortech Fibronic Inc., dated February
6, 2000 among
EXFO, Claude Adrien Noel, 9086-9314 Québec inc., Michel Bédard, Christine
Bergeron and Société en Commandite Capidem Québec Enr. and Certificate of
Closing, dated February 7, 2000 among the same parties (including
summary
in English) (incorporated by reference to Exhibit 10.2 of
EXFO’s
Registration Statement on Form F-1 filed on June 9, 2000,
File No.
333-38956).
|
4.6
|
Share
Purchase Agreement, dated as of March 5, 2001, among EXFO
Electro-Optical
Engineering, Inc., John Kennedy, Glenn Harvey and EFOS Corporation
(incorporated by reference to Exhibit 4.1 of EXFO’s Registration Statement
on Form F-3 filed on July 13, 2001, File No.
333-65122).
|
4.7
|
Amendment
Number One, dated as of March 15, 2001, to Share Purchase
Agreement, dated
as of March 5, 2001, among EXFO Electro-Optical Engineering,
Inc., John
Kennedy, Glenn Harvey and EFOS Corporation. (incorporated
by reference to
Exhibit 4.2 of EXFO’s Registration Statement on Form F-3 filed on July 13,
2001, File No. 333-65122).
|
4.8
|
Share
Purchase Agreement, dated as of November 2, 2001 between
JDS Uniphase Inc.
and 3905268 Canada Inc. (incorporated by reference to Exhibit
4.8 of
EXFO’s annual report on Form 20-F dated January 18, 2002, File
No.
000-30895).
|
4.9
|
Intellectual
Property Assignment and Sale Agreement between EFOS Inc.,
EXFO
Electro-Optical Engineering, Inc., John Kennedy, Glenn Harvey
and EFOS
Corporation. (incorporated by reference to Exhibit 4.3 of
EXFO’s
Registration Statement on Form F-3 filed on July 13, 2001,
File No.
333-65122).
|
4.10
|
Offer
to acquire a building, dated February 23, 2000, between EXFO
and Groupe
Mirabau inc. and as accepted by Groupe Mirabau inc. on February
24, 2000
(including summary in English) (incorporated by reference
to Exhibit 10.3
of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File
No. 333-38956).
|
4.11
|
Lease
Agreement, dated December 1, 1996, between EXFO and GEXFO
Investissements
Technologiques inc., as assigned to 9080-9823 Québec inc. on September 1,
1999 (including summary in English) (incorporated by reference
to Exhibit
10.4 of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File No. 333-38956).
|
4.12
|
Lease
Agreement, dated March 1, 1996, between EXFO and GEXFO Investissements
Technologiques inc., as assigned to 9080-9823 Québec inc. on September 1,
1999 (including summary in English) (incorporated by reference
to Exhibit
10.5 of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File No. 333-38956).
|
4.13
|
Lease
renewal of the existing leases between 9080-9823 Québec inc. and EXFO,
dated November 30, 2001(incorporated by reference to Exhibit
4.13 of
EXFO’s annual report on Form 20-F dated January 18, 2002, File
No.
000-30895).
|
4.14
|
Loan
Agreement between EXFO and GEXFO Investissements Technologiques
inc.,
dated May 11, 1993, as assigned to 9080-9823 Québec inc. on September
1, 1999 (including summary in English) (incorporated by
reference to Exhibit 10.9 of EXFO’s Registration Statement on Form F-1
filed on June 9, 2000, File No. 333-38956).
|
4.15
|
Resolution
of the Board of Directors of EXFO, dated September 1, 1999,
authorizing
EXFO to acquire GEXFO Distribution Internationale inc. from
GEXFO
Investissements Technologiques inc. (including summary in
English)
(incorporated by reference to Exhibit 10.10 of EXFO’s Registration
Statement on Form F-1 filed on June 9, 2000, File No.
333-38956).
|
4.16
|
Form
of Promissory Note of EXFO issued to GEXFO Investissements
Technologiques
inc. dated June 27, 2000 ) (incorporated by reference to
Exhibit 10.12 of EXFO’s Registration Statement on Form F-1 filed on June
9, 2000, File No. 333-38956).
|
4.17
|
Term
Loan Offer, dated March 28, 2000, among EXFO and National
Bank of Canada
as accepted by EXFO on April 3, 2000 (including summary in
English)
(incorporated by reference to Exhibit 10.11 of EXFO’s Registration
Statement on Form F-1 filed on June 9, 2000, File No.
333-38956).
|
4.18
|
Employment
Agreement of Germain Lamonde dated May 29, 2000 (incorporated
by reference
to Exhibit 10.15 of EXFO’s Registration Statement on Form F-1 filed on
June 9, 2000, File No. 333-38956).
|
4.19
|
Employment
Agreement of Bruce Bonini dated as of September 1, 2000 (incorporated
by
reference to Exhibit 4.24 of EXFO’s annual report on Form 20-F dated
January 18, 2002, File No. 000-30895).
|
4.20
|
Employment
Agreement of Juan-Felipe Gonzalez dated as of September 1,
2000
(incorporated by reference to Exhibit 4.25 of EXFO’s annual report on Form
20-F dated January 18, 2002, File No. 000-30895).
|
4.21
|
Employment
Agreement of David J. Farrell dated as of December 20, 2000
(incorporated
by reference to Exhibit 4.26 of EXFO’s annual report on Form 20-F dated
January 18, 2002, File No. 000-30895).
|
4.22
|
Deferred
Profit Sharing Plan, dated September 1, 1998 (incorporated
by reference to
Exhibit 10.6 of EXFO’s Registration Statement on Form F-1 filed on June 9,
2000, File No. 333-38956).
|
4.23
|
Stock
Option Plan, dated May 25, 2000 (incorporated by Reference
to Exhibit 10.7
of EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File
No. 333-38956).
|
4.24
|
Share
Plan, dated April 3, 2000 (incorporated by reference to Exhibit
10.8 of
EXFO’s Registration Statement on Form F-1 filed on June 9, 2000,
File No.
333-38956).
|
4.25
|
Directors’
Compensation Plan (incorporated by reference to Exhibit 10.17
of EXFO’s
Registration Statement on Form F-1 filed on June 9, 2000,
File No.
333-38956).
|
4.26
|
Restricted
Stock Award Plan, dated December 20, 2000 (incorporated by
reference to
Exhibit 4.21 of EXFO’s annual report on Form 20-F dated January 18, 2001,
File No. 000-30895).
|
4.27
|
Asset
Purchase Agreement by and Among EXFO Electro-Optical
Engineering Inc., EXFO Gnubi Products Group Inc., gnubi communications,
L.P., gnubi communications General Partner, LLC, gnubi communications
Limited Partner, LLC, gnubi communications, Inc., Voting
Trust created by
The Irrevocable Voting Trust Agreement Among Carol Abraham
Bolton, Paul
Abraham and James Ray Stevens, James Ray Stevens and Daniel
J. Ernst dated
September 5, 2002 (incorporated by reference to Exhibit 4.30
of EXFO’s
annual report on Form 20-F dated January 15, 2003, File No.
000-30895).
|
4.28
|
EXFO
Protocol Inc. Executive Employment Agreement with Sami Yazdi
signed
November 2, 2001 (incorporated by reference to Exhibit 4.28
of EXFO’s
annual report on Form 20-F dated January 15, 2003, File No.
000-30895).
|
4.29
|
Second
Amending Agreement to the Employment Agreement of Bruce Bonini
dated as of
September 1, 2002, (incorporated by reference to Exhibit
4.29 of EXFO’s
annual report on Form 20-F dated January 15, 2004, File No.
000-30895).
|
4.30
|
Severance
and General Release Agreement with Bruce Bonini dated August
8, 2003,
(incorporated by reference to Exhibit 4.30 of EXFO’s annual report on Form
20-F dated January 15, 2004, File No. 000-30895).
|
4.31
|
Separation
Agreement and General Release with Sami Yazdi dated April
1, 2003,
(incorporated by reference to Exhibit 4.31 of EXFO’s annual report on Form
20-F dated January 15, 2004, File No. 000-30895).
|
4.32
|
Executive
Employment Agreement of James Stevens dated as of October
4, 2003,
(incorporated by reference to Exhibit 4.32 of EXFO’s annual report on Form
20-F dated January 15, 2004, File No. 000-30895).
|
4.33
|
Termination
Terms for John Holloran Jr. dated May 28, 2003, (incorporated
by reference
to Exhibit 4.33 of EXFO’s annual report on Form 20-F dated January 15,
2004, File No. 000-30895).
|
4.34
|
Employment
Agreement of Pierre Plamondon dated as of September 1, 2002,
(incorporated
by reference to Exhibit 4.34 of EXFO’s annual report on Form 20-F dated
January 15, 2004, File No. 000-30895).
|
4.35
|
Long-Term
Incentive Plan, dated May 25, 2000, amended in October 2004
and effective
January 12, 2005 (incorporated by reference to Exhibit 4.35
of EXFO’s
annual report on Form 20-F dated November 29, 2005, File
No.
000-30895).
|
4.36
|
Deferred
Share Unit Plan, effective January 12, 2005 (incorporated
by reference to
Exhibit 4.36 of EXFO’s annual report on Form 20-F dated November 29, 2005,
File No. 000-30895).
|
4.37
|
Asset
Purchase Agreement by and Among EXFO Electro-Optical Engineering
Inc.,
Consultronics Limited., Andre Rekai, Consultronics Europe
Limited,
Consultronics Development Kft. and Consultronics Inc. dated
January 5,
2006 (incorporated by reference to Exhibit 4.37 of EXFO’s annual report on
Form 20-F dated November 23, 2006, File No. 000-30895).
|
8.1
|
Subsidiaries
of EXFO (list included in Item 4C of this annual
report).
|
11.1
|
Code
of Ethics for senior financial officers, (incorporated by
reference to
Exhibit 11.1 of EXFO’s annual report on Form 20-F dated January 15, 2004,
File No. 000-30895).
|
11.2
|
Board
of Directors Corporate Governance Guidelines (incorporated
by reference to
Exhibit 11.2 of EXFO’s annual report on Form 20-F dated November 29, 2005,
File No. 000-30895).
|
11.3
|
Code
of Ethics for our Principal Executive Officer and Senior
Financial
Officers (incorporated by reference to Exhibit 11.3 of EXFO’s annual
report on Form 20-F dated November 29, 2005, File No.
000-30895).
|
11.4
|
Ethics
and Business Conduct Policy (incorporated by reference to
Exhibit 11.4 of
EXFO’s annual report on Form 20-F dated November 29, 2005, File
No.
000-30895).
|
11.5
|
Statement
of Reporting Ethical Violations (Whistle Blower) (incorporated
by
reference to Exhibit 11.5 of EXFO’s annual report on Form 20-F dated
November 29, 2005, File No. 000-30895).
|
11.6
|
Audit
Committee Charter (incorporated by reference to Exhibit 11.6
of EXFO’s
annual report on Form 20-F dated November 29, 2005, File
No.
000-30895).
|
11.7
|
Human
Resources Committee Charter (incorporated by reference to
Exhibit 11.7 of
EXFO’s annual report on Form 20-F dated November 29, 2005, File
No.
000-30895).
|
12.1
|
Certification
of the Chief Executive Officer Pursuant to Section 302 of
the
Sarbanes-Oxley Act of 2002.
|
12.2
|
Certification
of the Chief Executive Officer Pursuant to Section 906 of
the
Sarbanes-Oxley Act of 2002.
|
13.1
|
Certification
of the Chief Financial Officer Pursuant to Section 302 of
the
Sarbanes-Oxley Act of 2002.
|
13.2
|
Certification
of the Chief Financial Officer Pursuant to Section 906 of
the
Sarbanes-Oxley Act of 2002.
|
1.
|
I
have reviewed this annual report on Form 20-F of EXFO Electro-Optical
Engineering Inc. ("EXFO");
|
2.
|
Based
on my knowledge, this report does not contain any untrue
statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which
such statements
were made, not misleading with respect to the period covered
by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial
information
included in this report, fairly present in all material respects
the
financial condition, results of operations and cash flows
of EXFO as at,
and for, the periods presented in this
report;
|
4.
|
EXFO's
other certifying officer and I are responsible for establishing
and
maintaining disclosure controls and procedures (as defined
in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for EXFO and have:
|
a.
|
Designed
such disclosure controls and procedures or caused such disclosure
controls
and procedures to be designed under our supervision, to ensure that
material information relating to EXFO, including its consolidated
subsidiaries, is made known to us by others within those
entities,
particularly during the period in which this report is being
prepared;
|
b.
|
Designed
such internal control over financial reporting, or caused
such internal
control over financial reporting to be designed under our
supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for
external
purposes in accordance with generally accepted accounting
principles;
|
c.
|
Evaluated
the effectiveness of EXFO's disclosure controls and procedures
and
presented in this report our conclusions about the effectiveness
of the
disclosure controls and procedures, as at the end of the
period covered by
this report based on such evaluation;
and
|
d.
|
Disclosed
in this report any change in EXFO's internal control over
financial
reporting that occurred during the period covered by the
annual report
that has materially affected, or is reasonably likely to
materially
affect, EXFO's internal control over financial
reporting.
|
5.
|
EXFO's
other certifying officer and I have disclosed, based on our
most recent
evaluation of internal control over financial reporting,
to EXFO's
auditors and the audit committee of EXFO's board of
directors:
|
a.
|
All
significant deficiencies and material weaknesses in the design
or
operation of internal control over financial reporting which
are
reasonably likely to adversely affect EXFO's ability to record,
process,
summarize and report financial information;
and
|
b.
|
Any
fraud, whether or not material, that involves management
or other
employees who have a significant role in EXFO’s internal control over
financial reporting.
|
1.
|
The
annual report of Form 20-F for the year ended August 31,
2007 of EXFO
fully complies with the requirements of section 13(a) or
15(d) of the
Securities Exchange Act of 1934;
and
|
2.
|
The
information contained in this annual report fairly presents,
in all
material respects, the financial condition and results of
operations of
EXFO.
|
1.
|
I
have reviewed this annual report on Form 20-F of EXFO Electro-Optical
Engineering Inc. ("EXFO");
|
2.
|
Based
on my knowledge, this report does not contain any untrue
statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which
such statements
were made, not misleading with respect to the period covered
by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial
information
included in this report, fairly present in all material respects
the
financial condition, results of operations and cash flows
of EXFO as at,
and for, the periods presented in this
report;
|
4.
|
EXFO's
other certifying officer and I are responsible for establishing
and
maintaining disclosure controls and procedures (as defined
in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for EXFO and have:
|
a.
|
Designed
such disclosure controls and procedures or caused such disclosure
controls
and procedures to be designed under our supervision, to ensure that
material information relating to EXFO, including its consolidated
subsidiaries, is made known to us by others within those
entities,
particularly during the period in which this report is being
prepared;
|
b.
|
Designed
such internal control over financial reporting, or caused
such internal
control over financial reporting to be designed under our
supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for
external
purposes in accordance with generally accepted accounting
principles;
|
c.
|
Evaluated
the effectiveness of EXFO's disclosure controls and procedures
and
presented in this report our conclusions about the effectiveness
of the
disclosure controls and procedures, as at the end of the
period covered by
this report based on such evaluation;
and
|
d.
|
Disclosed
in this report any change in EXFO's internal control over
financial
reporting that occurred during the period covered by the
annual report
that has materially affected, or is reasonably likely to
materially
affect, EXFO's internal control over financial
reporting.
|
5.
|
EXFO's
other certifying officer and I have disclosed, based on our
most recent
evaluation of internal control over financial reporting,
to EXFO's
auditors and the audit committee of EXFO's board of
directors:
|
a.
|
All
significant deficiencies and material weaknesses in the design
or
operation of internal control over financial reporting which
are
reasonably likely to adversely affect EXFO's ability to record,
process,
summarize and report financial information;
and
|
b.
|
Any
fraud, whether or not material, that involves management
or other
employees who have a significant role in EXFO's internal control over
financial reporting.
|
1.
|
The
annual report of Form 20-F for the year ended August 31,
2007 of EXFO
fully complies with the requirements of section 13(a) or
15(d) of the
Securities Exchange Act of 1934;
and
|
2.
|
The
information contained in this annual report fairly presents,
in all
material respects, the financial condition and results of
operations of
EXFO.
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Assets
|
||||||||
Current
assets
|
||||||||
Cash
|
$ |
5,541
|
$ |
6,853
|
||||
Short-term
investments (notes 8 and 18)
|
124,217
|
104,437
|
||||||
Accounts
receivable (notes 8 and 18)
|
||||||||
Trade
|
26,699
|
20,891
|
||||||
Other
(note 4)
|
2,479
|
2,792
|
||||||
Income
taxes and tax credits recoverable (note 15)
|
6,310
|
2,201
|
||||||
Inventories
(notes 5 and 8)
|
31,513
|
24,623
|
||||||
Prepaid
expenses
|
1,391
|
1,404
|
||||||
Future
income taxes (note 16)
|
7,609
|
−
|
||||||
205,759
|
163,201
|
|||||||
Income
taxes recoverable
|
−
|
476
|
||||||
Property,
plant and equipment (notes 6 and 8)
|
18,117
|
17,392
|
||||||
Intangible
assets (notes 7 and 8)
|
9,628
|
10,948
|
||||||
Goodwill
(note 7)
|
28,437
|
27,142
|
||||||
Future
income taxes (note 16)
|
17,197
|
−
|
||||||
$ |
279,138
|
$ |
219,159
|
|||||
Liabilities
|
||||||||
Current
liabilities
|
||||||||
Accounts
payable and accrued liabilities (note 9)
|
$ |
22,721
|
$ |
17,337
|
||||
Deferred
revenue
|
2,598
|
1,772
|
||||||
Current
portion of long-term debt
|
−
|
107
|
||||||
25,319
|
19,216
|
|||||||
Deferred
revenue
|
3,414
|
2,632
|
||||||
Government
grants (note 15)
|
−
|
723
|
||||||
Long-term
debt (note 10)
|
−
|
354
|
||||||
Future
income taxes (note 16)
|
240
|
−
|
||||||
28,973
|
22,925
|
|||||||
Commitments
(note 11)
|
||||||||
Contingencies
(note 12)
|
||||||||
Shareholders’
equity
|
||||||||
Share
capital (note 13)
|
150,019
|
148,921
|
||||||
Contributed
surplus
|
4,453
|
3,776
|
||||||
Retained
earnings (note 13)
|
42,275
|
−
|
||||||
Cumulative
translation adjustment
|
53,418
|
43,537
|
||||||
250,165
|
196,234
|
|||||||
$ |
279,138
|
$ |
219,159
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Sales
(note 19)
|
$ |
152,934
|
$ |
128,253
|
$ |
97,216
|
||||||
Cost
of sales (1,2)
|
65,136
|
57,275
|
44,059
|
|||||||||
Gross
margin
|
87,798
|
70,978
|
53,157
|
|||||||||
Operating
expenses
|
||||||||||||
Selling
and administrative (1)
|
49,580
|
40,298
|
31,782
|
|||||||||
Net
research and development (1) (notes
15
and 16)
|
16,668
|
15,404
|
12,190
|
|||||||||
Amortization
of property, plant and equipment
|
2,983
|
3,523
|
4,256
|
|||||||||
Amortization
of intangible assets
|
2,864
|
4,394
|
4,836
|
|||||||||
Impairment
of long-lived assets (note 4)
|
–
|
604
|
–
|
|||||||||
Government
grants (note 15)
|
(1,079 | ) | (1,307 | ) |
–
|
|||||||
Restructuring
and other charges (note 4)
|
–
|
–
|
292
|
|||||||||
Total
operating expenses
|
71,016
|
62,916
|
53,356
|
|||||||||
Earnings
(loss) from operations
|
16,782
|
8,062
|
(199 | ) | ||||||||
Interest
and other income
|
4,717
|
3,253
|
2,524
|
|||||||||
Foreign
exchange loss
|
(49 | ) | (595 | ) | (1,336 | ) | ||||||
Earnings
before income taxes (note 16)
|
21,450
|
10,720
|
989
|
|||||||||
Income
taxes (note 16)
|
||||||||||||
Current
|
3,741
|
2,585
|
2,623
|
|||||||||
Recognition
of previously unrecognized future income tax assets
|
(24,566 | ) |
–
|
–
|
||||||||
(20,825 | ) |
2,585
|
2,623
|
|||||||||
Net
earnings (loss) for the year
|
$ |
42,275
|
$ |
8,135
|
$ | (1,634 | ) | |||||
Basic
and diluted net earnings (loss) per share
|
$ |
0.61
|
$ |
0.12
|
$ | (0.02 | ) | |||||
Basic
weighted average number of shares
outstanding (000’s)
|
68,875
|
68,643
|
68,526
|
|||||||||
Diluted
weighted average number of shares outstanding (000’s) (note
17)
|
69,555
|
69,275
|
68,526
|
|||||||||
(1)
Stock-based compensation costs included
in:
|
||||||||||||
Cost
of sales
|
$ |
118
|
$ |
127
|
$ |
143
|
||||||
Selling
and administrative
|
633
|
701
|
626
|
|||||||||
Net
research and development
|
230
|
204
|
194
|
|||||||||
$ |
981
|
$ |
1,032
|
$ |
963
|
|||||||
(2)
The cost of sales is exclusive of amortization, shown
separately.
|
Retained
earnings (deficit)
|
||||||||||||
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Balance
– Beginning of year
|
$ |
–
|
$ | (381,846 | ) | $ | (380,212 | ) | ||||
Add
(deduct)
|
||||||||||||
Net
earnings (loss) for the year
|
42,275
|
8,135
|
(1,634 | ) | ||||||||
Elimination
of deficit by reduction of share capital (note 13)
|
–
|
373,711
|
–
|
|||||||||
Balance
– End of year
|
$ |
42,275
|
$ |
–
|
$ | (381,846 | ) | |||||
Contributed
surplus
|
||||||||||||
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Balance
– Beginning of year
|
$ |
3,776
|
$ |
2,949
|
$ |
1,986
|
||||||
Add
(deduct)
|
||||||||||||
Stock-based
compensation costs
|
973
|
1,027
|
963
|
|||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise
of stock
awards (note 13)
|
(296 | ) | (200 | ) |
–
|
|||||||
Balance
– End of year
|
$ |
4,453
|
$ |
3,776
|
$ |
2,949
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Cash
flows from operating activities
|
||||||||||||
Net
earnings (loss) for the year
|
$ |
42,275
|
$ |
8,135
|
$ | (1,634 | ) | |||||
Add
(deduct) items not affecting cash
|
||||||||||||
Discount
on short-term investments
|
(404 | ) | (229 | ) | (302 | ) | ||||||
Stock-based
compensation costs
|
981
|
1,032
|
963
|
|||||||||
Amortization
|
5,847
|
7,917
|
9,092
|
|||||||||
Impairment
of long-lived assets
|
–
|
604
|
–
|
|||||||||
Gain
on disposal of capital assets
|
(117 | ) |
–
|
–
|
||||||||
Future
income taxes
|
(24,566 | ) |
–
|
–
|
||||||||
Deferred
revenue
|
1,299
|
786
|
977
|
|||||||||
Government
grants
|
(752 | ) | (1,307 | ) |
–
|
|||||||
24,563
|
16,938
|
9,096
|
||||||||||
Change
in non-cash operating items
|
||||||||||||
Accounts
receivable
|
(5,468 | ) | (2,637 | ) | (838 | ) | ||||||
Income
taxes and tax credits
|
(3,403 | ) |
329
|
6,096
|
||||||||
Inventories
|
(5,456 | ) | (2,287 | ) | (699 | ) | ||||||
Prepaid
expenses
|
85
|
79
|
544
|
|||||||||
Accounts
payable and accrued liabilities
|
4,105
|
(144 | ) | (164 | ) | |||||||
14,426
|
12,278
|
14,035
|
||||||||||
Cash
flows from investing activities
|
||||||||||||
Additions
to short-term investments
|
(807,056 | ) | (673,289 | ) | (585,665 | ) | ||||||
Proceeds
from disposal and maturity of short-term investments
|
793,435
|
681,500
|
574,207
|
|||||||||
Additions
to capital assets
|
(5,547 | ) | (3,378 | ) | (1,501 | ) | ||||||
Net
proceeds from disposal of capital assets
|
3,092
|
–
|
–
|
|||||||||
Business
combination, net of cash acquired (note 3)
|
–
|
(18,054 | ) |
–
|
||||||||
(16,076 | ) | (13,221 | ) | (12,959 | ) | |||||||
Cash
flows from financing activities
|
||||||||||||
Repayment
of long-term debt
|
(472 | ) | (415 | ) | (121 | ) | ||||||
Exercise
of stock options
|
802
|
557
|
148
|
|||||||||
Share
issue expenses
|
–
|
–
|
(6 | ) | ||||||||
330
|
142
|
21
|
||||||||||
Effect
of foreign exchange rate changes on cash
|
8
|
535
|
863
|
|||||||||
Change
in cash
|
(1,312 | ) | (266 | ) |
1,960
|
|||||||
Cash
– Beginning of year
|
6,853
|
7,119
|
5,159
|
|||||||||
Cash
– End of year
|
$ |
5,541
|
$ |
6,853
|
$ |
7,119
|
||||||
Supplementary
information
|
||||||||||||
Interest
paid
|
$ |
57
|
$ |
65
|
$ |
30
|
||||||
Income
taxes paid (recovered)
|
$ |
3,527
|
$ |
2,541
|
$ | (669 | ) |
Term
|
||
Land
improvements
|
5
years
|
|
Buildings
|
25
years
|
|
Equipment
|
2
to 10 years
|
|
Leasehold
improvements
|
The
lesser of useful life and remaining lease
term
|
Assets
acquired
|
||||
Current
assets, net of cash acquired
|
$ |
5,135
|
||
Property,
plant and equipment
|
3,115
|
|||
Core
technology
|
8,709
|
|||
Current
liabilities assumed
|
(2,826 | ) | ||
Loans
assumed
|
(402 | ) | ||
Net
identifiable assets acquired
|
13,731
|
|||
Goodwill
|
5,107
|
|||
Purchase
price, net of cash acquired
|
$ |
18,838
|
Balance
as at
August
31,
2006
|
Additions
|
Payments
|
Adjustments
|
Balance
as at
August
31,
2007
|
||||||||||||||||
Fiscal 2006 plan
|
||||||||||||||||||||
Severance expenses (note 3)
|
$ |
631
|
$ |
−
|
$ | (631 | ) | $ |
−
|
$ |
−
|
|||||||||
Fiscal 2003 plan
|
||||||||||||||||||||
Exited leased facilities
|
60
|
−
|
(60 | ) |
−
|
−
|
||||||||||||||
Total for all plans (note 9)
|
$ |
691
|
$ |
−
|
$ | (691 | ) | $ |
−
|
$ |
−
|
Balance
as at
August
31,
2005
|
Additions
|
Payments
|
Adjustments
|
Balance
as at
August
31,
2006
|
||||||||||||||||
Fiscal 2006 plan
|
||||||||||||||||||||
Severance expenses (note 3)
|
$ |
–
|
$ |
660
|
$ | (29 | ) | $ |
–
|
$ |
631
|
|||||||||
Fiscal 2003 plan
|
||||||||||||||||||||
Exited leased facilities
|
150
|
–
|
(90 | ) |
–
|
60
|
||||||||||||||
Total for all plans (note 9)
|
$ |
150
|
$ |
660
|
$ | (119 | ) | $ |
–
|
$ |
691
|
Balance
as at
August
31,
2004
|
Additions
|
Payments
|
Adjustments
|
Balance
as at
August
31,
2005
|
||||||||||||||||
Fiscal 2004 plan
|
||||||||||||||||||||
Severance expenses
|
$ |
467
|
$ |
83
|
$ | (550 | ) | $ |
−
|
$ |
−
|
|||||||||
Other
|
−
|
399
|
(399 | ) |
−
|
−
|
||||||||||||||
467
|
482
|
(949 | ) |
−
|
−
|
|||||||||||||||
Fiscal 2003 plan
|
||||||||||||||||||||
Severance expenses
|
109
|
−
|
(77 | ) | (32 | ) |
−
|
|||||||||||||
Exited leased facilities
|
386
|
−
|
(229 | ) | (7 | ) |
150
|
|||||||||||||
Other
|
197
|
−
|
(46 | ) | (151 | ) |
−
|
|||||||||||||
692
|
−
|
(352 | ) | (190 | ) |
150
|
||||||||||||||
Fiscal 2001 plan
|
||||||||||||||||||||
Exited leased facilities
|
10
|
−
|
(10 | ) |
−
|
−
|
||||||||||||||
Total for all plans
|
$ |
1,169
|
$ |
482
|
$ | (1,311 | ) | $ | (190 | ) | $ |
150
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Raw
materials
|
$ |
16,898
|
$ |
14,353
|
||||
Work
in progress
|
1,387
|
1,043
|
||||||
Finished
goods
|
13,228
|
9,227
|
||||||
$ |
31,513
|
$ |
24,623
|
As
at August 31,
|
||||||||||||||||
2007
|
2006
|
|||||||||||||||
Cost
|
Accumulated
amortization
|
Cost
|
Accumulated
amortization
|
|||||||||||||
Land
and land improvements
|
$ |
2,265
|
$ |
1,177
|
$ |
4,249
|
$ |
1,082
|
||||||||
Buildings
|
12,300
|
3,516
|
14,417
|
6,262
|
||||||||||||
Equipment
|
33,184
|
25,710
|
33,562
|
28,263
|
||||||||||||
Leasehold
improvements
|
3,236
|
2,465
|
2,788
|
2,017
|
||||||||||||
50,985
|
$ |
32,868
|
55,016
|
$ |
37,624
|
|||||||||||
Less:
|
||||||||||||||||
Accumulated
amortization
|
32,868
|
37,624
|
||||||||||||||
$ |
18,117
|
$ |
17,392
|
As
at August 31,
|
||||||||||||||||
2007
|
2006
|
|||||||||||||||
Cost
|
Accumulated
amortization
|
Cost
|
Accumulated
amortization
|
|||||||||||||
Core
technology
|
$ |
50,014
|
$ |
43,298
|
$ |
47,629
|
$ |
38,972
|
||||||||
Software
|
8,083
|
5,171
|
6,781
|
4,490
|
||||||||||||
58,097
|
$ |
48,469
|
54,410
|
$ |
43,462
|
|||||||||||
Less:
|
||||||||||||||||
Accumulated
amortization
|
48,469
|
43,462
|
||||||||||||||
$ |
9,628
|
$ |
10,948
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Balance
– Beginning of year
|
$ |
27,142
|
$ |
20,370
|
||||
Addition
from business combination (note 3)
|
−
|
5,107
|
||||||
Foreign
currency translation adjustment
|
1,295
|
1,665
|
||||||
|
||||||||
Balance
– End of year (note 19)
|
$ |
28,437
|
$ |
27,142
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Trade
|
$ |
11,749
|
$ |
7,487
|
||||
Salaries
and social benefits
|
7,929
|
5,991
|
||||||
Warranty
|
800
|
1,006
|
||||||
Commissions
|
824
|
835
|
||||||
Restructuring
charges (note 4)
|
−
|
691
|
||||||
Other
|
1,419
|
1,327
|
||||||
$ |
22,721
|
$ |
17,337
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Balance
– Beginning of year
|
$ |
1,006
|
$ |
725
|
||||
Provision
|
801
|
895
|
||||||
Settlements
|
(1,007 | ) | (645 | ) | ||||
Addition
from business combination
|
−
|
31
|
||||||
Balance
– End of year
|
$ |
800
|
$ |
1,006
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Loans
collateralized by equipment, bearing interest at 4.9%, fully
repaid in
fiscal 2007
|
$ |
−
|
$ |
461
|
||||
Less:
Current portion
|
−
|
107
|
||||||
$ |
−
|
$ |
354
|
|
Subordinate
voting and participating, bearing a non-cumulative dividend
to be
determined by the Board of Directors, ranking
pari passu with multiple voting
shares
|
|
Multiple
voting and participating, entitling to ten votes each, bearing
a
non-cumulative dividend to be determined by the Board of
Directors,
convertible at the holder’s option into subordinate voting shares on a
one-for- one basis, ranking pari passu with subordinate voting
shares
|
Multiple
voting shares
|
Subordinate
voting shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total amount
|
||||||||||||||||
Balance
as at August 31, 2004
|
37,900,000
|
$ |
1
|
30,540,483
|
$ |
521,732
|
$ |
521,733
|
||||||||||||
Exercise
of stock options (note 14)
|
–
|
–
|
71,699
|
148
|
148
|
|||||||||||||||
Redemption
of restricted stock awards
|
–
|
–
|
53,592
|
–
|
–
|
|||||||||||||||
Share
issue expenses
|
–
|
–
|
–
|
(6 | ) | (6 | ) | |||||||||||||
Balance
as at August 31, 2005
|
37,900,000
|
1
|
30,665,774
|
521,874
|
521,875
|
|||||||||||||||
Exercise
of stock options (note 14)
|
–
|
–
|
182,425
|
557
|
557
|
|||||||||||||||
Redemption
of restricted share units (note 14)
|
–
|
–
|
4,770
|
–
|
–
|
|||||||||||||||
Conversion
of multiple voting shares into subordinate voting shares
|
(757,000 | ) |
–
|
757,000
|
–
|
–
|
||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise
of stock
awards
|
–
|
–
|
–
|
200
|
200
|
|||||||||||||||
Elimination
of deficit by reduction of share capital (1)
|
–
|
–
|
–
|
(373,711 | ) | (373,711 | ) | |||||||||||||
Balance
as at August 31, 2006
|
37,143,000
|
1
|
31,609,969
|
148,920
|
148,921
|
|||||||||||||||
Exercise
of stock options (note 14)
|
–
|
–
|
250,528
|
802
|
802
|
|||||||||||||||
Redemption
of restricted share units (note 14)
|
–
|
–
|
1,064
|
–
|
–
|
|||||||||||||||
Conversion
of multiple voting shares into subordinate voting shares
|
(500,000 | ) |
–
|
500,000
|
–
|
–
|
||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise
of stock
awards
|
–
|
–
|
–
|
296
|
296
|
|||||||||||||||
Balance
as at August 31, 2007
|
36,643,000
|
$ |
1
|
32,361,561
|
$ |
150,018
|
$ |
150,019
|
(1)
|
On
August 31, 2006, upon the approval of the Board of Directors,
the company
eliminated its deficit against its share
capital.
|
Years
ended August 31,
|
||||||||||||||||||||||||
2007
|
2006
|
2005
|
||||||||||||||||||||||
Number
|
Weighted
average
exercise
price
|
Number
|
Weighted
average
exercise
price
|
Number
|
Weighted
average
exercise
price
|
|||||||||||||||||||
(CA$)
|
(CA$)
|
(CA$)
|
||||||||||||||||||||||
Outstanding
– Beginning of year
|
2,439,375
|
$ |
20
|
2,763,759
|
$ |
19
|
2,934,518
|
$ |
21
|
|||||||||||||||
Granted
|
−
|
−
|
31,992
|
6
|
246,233
|
6
|
||||||||||||||||||
Exercised
|
(250,528 | ) | (4 | ) | (182,425 | ) | (4 | ) | (71,699 | ) | (3 | ) | ||||||||||||
Forfeited
|
(259,459 | ) | (32 | ) | (173,951 | ) | (18 | ) | (345,293 | ) | (27 | ) | ||||||||||||
Outstanding
– End of year
|
1,929,388
|
$ |
21
|
2,439,375
|
$ |
20
|
2,763,759
|
$ |
19
|
|||||||||||||||
Exercisable
– End of year
|
1,746,699
|
$ |
22
|
1,852,870
|
$ |
25
|
1,650,404
|
$ |
28
|
Years
ended August 31,
|
||||
2006
|
2005
|
|||
Risk-free
interest rate
|
3.9%
|
3.6%
|
||
Expected
volatility
|
87%
|
95%
|
||
Dividend
yield
|
Nil
|
Nil
|
||
Expected
life
|
66
months
|
66
months
|
|
Stock
options outstanding
|
Stock
options exercisable
|
||||||||||||||
Exercise
price
|
Number
|
Weighted
average
exercise
price
|
Intrinsic
value
|
Weighted
average
remaining
contractual
life
|
Number
|
Weighted
average
exercise
price
|
Intrinsic
value
|
Weighted
average
remaining
contractual
life
|
||||||||
(CA$)
|
|
|
(CA$)
|
(CA$)
|
(CA$)
|
(CA$)
|
||||||||||
$2.50
to $3.36
|
280,625
|
$ 2.51
|
$1,280
|
5.1
years
|
280,625
|
$ 2.51
|
$1,280
|
5.1
years
|
||||||||
$3.96
to $5.84
|
429,404
|
5.11
|
841
|
6.7
years
|
285,133
|
5.01
|
587
|
6.4
years
|
||||||||
$6.22
to $9.02
|
157,316
|
6.58
|
116
|
6.4
years
|
118,898
|
6.70
|
83
|
6.3
years
|
||||||||
$14.27
to $20.00
|
412,296
|
15.61
|
−
|
4.1
years
|
412,296
|
15.61
|
−
|
4.1
years
|
||||||||
$29.70
to $43.00
|
468,926
|
36.36
|
−
|
3.2
years
|
468,926
|
36.36
|
−
|
3.2
years
|
||||||||
$51.25
to $68.17
|
143,391
|
66.58
|
−
|
3.0
years
|
143,391
|
66.58
|
−
|
3.0
years
|
||||||||
$83.66
|
37,430
|
83.66
|
−
|
3.0
years
|
37,430
|
83.66
|
−
|
3.0
years
|
||||||||
1,929,388
|
$20.78
|
$2,237
|
4.7
years
|
1,746,699
|
$ 22.38
|
$1,950
|
4.4
years
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Outstanding
– Beginning of year
|
327,877
|
176,185
|
–
|
|||||||||
Granted
|
219,002
|
173,803
|
176,185
|
|||||||||
Redeemed
|
(1,064 | ) | (4,770 | ) |
–
|
|||||||
Forfeited
|
(57,800 | ) | (17,341 | ) |
–
|
|||||||
Outstanding
– End of year
|
488,015
|
327,877
|
176,185
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Outstanding
– Beginning of year
|
43,290
|
23,734
|
–
|
|||||||||
Granted
|
21,428
|
19,556
|
23,734
|
|||||||||
Outstanding
– End of year
|
64,718
|
43,290
|
23,734
|
Years
ended August 31,
|
||||||||||||||||||||||||
2007
|
2006
|
2005
|
||||||||||||||||||||||
Number
|
Weighted
average exercise
price
|
Number
|
Weighted
average exercise
price
|
Number
|
Weighted
average exercise
price
|
|||||||||||||||||||
Outstanding
– Beginning of year
|
24,500
|
$ |
11
|
19,000
|
$ |
12
|
13,000
|
$ |
16
|
|||||||||||||||
Granted
|
5,200
|
6
|
5,500
|
6
|
6,000
|
4
|
||||||||||||||||||
Forfeited
|
(2,000 | ) | (2 | ) |
–
|
–
|
–
|
–
|
||||||||||||||||
Outstanding
– End of year
|
27,700
|
$ |
11
|
24,500
|
$ |
11
|
19,000
|
$ |
12
|
|||||||||||||||
Exercisable
– End of year
|
13,875
|
$ |
15
|
11,000
|
$ |
18
|
7,500
|
$ |
24
|
Stock
appreciation
rights
outstanding
|
Stock
appreciation
rights
exercisable
|
||||||
Exercise
price
|
Number
|
Weighted
average remaining contractual life
|
Number
|
||||
$4.51
to $6.50
|
22,700
|
7.9
years
|
8,875
|
||||
$22.25
|
2,500
|
3.4
years
|
|
2,500
|
|||
$45.94
|
2,500
|
3.0
years
|
2,500
|
||||
27,700
|
6.6
years
|
13,875
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Gross
research and development expenses
|
$ |
25,201
|
$ |
19,488
|
$ |
15,878
|
||||||
Research
and development tax credits and grants
|
(5,371 | ) | (4,084 | ) | (3,688 | ) | ||||||
Recognition
of previously unrecognized research and development tax credits
(note
16)
|
(3,162 | ) |
–
|
–
|
||||||||
$ |
16,668
|
$ |
15,404
|
$ |
12,190
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Cost
of sales
|
$ |
186
|
$ |
262
|
$ |
89
|
||||||
Selling
and administrative
|
$ |
11
|
$ |
76
|
$ |
32
|
||||||
Net
research and development
|
$ |
9
|
$ |
4
|
$ |
22
|
||||||
Government
grants
|
$ |
1,079
|
$ |
1,307
|
$ |
–
|
·
|
Deferred
profit-sharing plan
|
·
|
401K
plan
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Income
tax provision at combined Canadian federal and provincial statutory
tax
rate (32% in 2007 and 2006 and 31% in 2005)
|
$ |
6,864
|
$ |
3,430
|
$ |
307
|
||||||
Increase
(decrease) due to:
|
||||||||||||
Foreign
income taxed at different rates
|
(12 | ) | (85 | ) | (580 | ) | ||||||
Non-taxable
income
|
(109 | ) | (207 | ) | (827 | ) | ||||||
Non-deductible
expenses
|
692
|
527
|
784
|
|||||||||
Tax
deductions
|
–
|
–
|
(81 | ) | ||||||||
Change
in tax rates
|
105
|
497
|
–
|
|||||||||
Foreign
exchange effect of translation of foreign integrated
subsidiaries
|
45
|
61
|
(209 | ) | ||||||||
Other
|
236
|
239
|
(146 | ) | ||||||||
Recognition
of previously unrecognized future income tax assets
|
(24,566 | ) |
–
|
–
|
||||||||
Utilization
of previously unrecognized future income tax
assets
|
(4,080 | ) | (1,877 | ) |
–
|
|||||||
Unrecognized future
income tax assets on temporary deductible differences and unused
tax
losses and deductions
|
–
|
–
|
3,375
|
|||||||||
$ | (20,825 | ) | $ |
2,585
|
$ |
2,623
|
||||||
The
income tax provision consists of the following:
|
||||||||||||
Current
|
||||||||||||
Canadian
|
$ |
3,568
|
$ |
2,573
|
$ |
2,513
|
||||||
Other
|
173
|
12
|
110
|
|||||||||
3,741
|
2,585
|
2,623
|
||||||||||
Future
|
||||||||||||
Canadian
|
3,726
|
2,687
|
(1,445 | ) | ||||||||
United
States
|
428
|
(601 | ) | (1,723 | ) | |||||||
Other
|
(74 | ) | (209 | ) | (207 | ) | ||||||
4,080
|
1,877
|
(3,375 | ) | |||||||||
Valuation
allowance
|
||||||||||||
Canadian
|
(23,092 | ) | (2,687 | ) |
1,445
|
|||||||
United
States
|
(5,628 | ) |
601
|
1,723
|
||||||||
Other
|
74
|
209
|
207
|
|||||||||
(28,646 | ) | (1,877 | ) |
3,375
|
||||||||
(24,566 | ) |
–
|
–
|
|||||||||
$ | (20,825 | ) | $ |
2,585
|
$ |
2,623
|
||||||
Details
of the company’s income taxes:
|
||||||||||||
Earnings
(loss) before income taxes
|
||||||||||||
Canadian
|
$ |
19,634
|
$ |
13,202
|
$ |
3,092
|
||||||
United
States
|
1,059
|
(2,103 | ) | (953 | ) | |||||||
Other
|
757
|
(379 | ) | (1,150 | ) | |||||||
$ |
21,450
|
$ |
10,720
|
$ |
989
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Future
income tax assets
|
||||||||
Long-lived
assets
|
$ |
4,304
|
$ |
4,453
|
||||
Provisions
and accruals
|
6,257
|
7,315
|
||||||
Deferred
revenue
|
1,005
|
486
|
||||||
Share
issue expenses
|
106
|
531
|
||||||
Research
and development expenses
|
10,422
|
8,527
|
||||||
Losses
carried forward
|
17,230
|
18,118
|
||||||
39,324
|
39,430
|
|||||||
Valuation
allowance
|
(12,492 | ) | (38,543 | ) | ||||
26,832
|
887
|
|||||||
Future
income tax liabilities
|
||||||||
Research
and development tax credits
|
(2,026 | ) | (887 | ) | ||||
Provisions
and accruals
|
(240 | ) |
–
|
|||||
(2,266 | ) | (887 | ) | |||||
Future
income tax assets, net
|
$ |
24,566
|
$ |
–
|
Canada
|
|
United
States
|
||||||||||
Year
of expiry
|
Federal
|
Provinces
|
and
Other
|
|||||||||
2008
|
$ |
1,230
|
$ |
869
|
$ |
–
|
||||||
2009
|
2,845
|
162
|
–
|
|||||||||
2010
|
4,663
|
176
|
–
|
|||||||||
2014
|
177
|
84
|
–
|
|||||||||
2015
|
1,181
|
1,181
|
–
|
|||||||||
2022
|
–
|
–
|
3,795
|
|||||||||
2023
|
–
|
–
|
7,499
|
|||||||||
2024
|
–
|
–
|
4,564
|
|||||||||
2025
|
–
|
–
|
5,217
|
|||||||||
2026
|
1,081
|
1,081
|
2,308
|
|||||||||
2027
|
1,103
|
1,103
|
–
|
|||||||||
Indefinite
|
1,523
|
1,855
|
17,610
|
|||||||||
$ |
13,803
|
$ |
6,511
|
$ |
40,993
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
Basic
weighted average number of shares
outstanding
(000’s)
|
68,875
|
68,643
|
68,526
|
|||||||||
Plus
dilutive effect of:
|
||||||||||||
Stock
options (000’s)
|
448
|
502
|
422
|
|||||||||
Restricted
share units (000’s)
|
179
|
99
|
8
|
|||||||||
Deferred
share units (000’s)
|
53
|
31
|
8
|
|||||||||
Restricted
stock awards (000’s)
|
−
|
−
|
17
|
|||||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,555
|
69,275
|
68,981
|
|||||||||
Stock
awards excluded from the calculation of the diluted weighted
average
number of shares outstanding because their exercise price was
greater than
the average market price of the common shares (000’s)
|
1,207
|
1,628
|
1,962
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Commercial
paper denominated in Canadian dollars, bearing interest at
annual rates of
3.98% to 4.67% in 2007 and 3.92% to 4.31% in 2006, maturing
on different
dates between September 2007 and January 2008 in fiscal 2007,
and
September 2006 and January 2007 in fiscal 2006
|
$ |
124,217
|
$ |
104,437
|
Cash
|
Non-interest
bearing
|
|
Short-term
investments
|
As
described above
|
|
Accounts
receivable
|
Non-interest
bearing
|
|
Accounts
payable and accrued liabilities
|
Non-interest
bearing
|
Contractual
amounts
|
Weighted
average contractual
forward
rates
|
|||||||
As
at August 31, 2006
|
||||||||
September
2006 to August 2007
|
$ |
37,000
|
1.1676
|
|||||
September
2007 to June 2009
|
26,800
|
1.1261
|
||||||
As
at August 31, 2007
|
||||||||
September
2007 to August 2008
|
$ |
36,900
|
1.1295
|
|||||
September
2008 to December 2009
|
15,400
|
1.1199
|
Year
ended August 31, 2007
|
||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
||||||||||
Sales
|
$ |
129,839
|
$ |
23,095
|
$ |
152,934
|
||||||
Earnings
from operations
|
$ |
13,132
|
$ |
3,650
|
$ |
16,782
|
||||||
Unallocated
items:
|
||||||||||||
Interest
and other income
|
4,717
|
|||||||||||
Foreign
exchange loss
|
(49 | ) | ||||||||||
Earnings
before income taxes
|
21,450
|
|||||||||||
Income
taxes
|
(20,825 | ) | ||||||||||
Net
earnings for the year
|
$ |
42,275
|
||||||||||
Recognition
of previously unrecognized research and development tax credits
(note
15)
|
$ | (3,162 | ) | $ |
−
|
$ | (3,162 | ) | ||||
Government
grants (note 15)
|
$ | (1,079 | ) | $ |
−
|
$ | (1,079 | ) | ||||
Amortization
of capital assets
|
$ |
5,557
|
$ |
290
|
$ |
5,847
|
||||||
Stock-based
compensation costs
|
$ |
886
|
$ |
95
|
$ |
981
|
||||||
Capital
expenditures
|
$ |
5,424
|
$ |
123
|
$ |
5,547
|
Year
ended August 31, 2006
|
||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
||||||||||
Sales
|
$ |
107,376
|
$ |
20,877
|
$ |
128,253
|
||||||
Earnings
from operations
|
$ |
6,679
|
$ |
1,383
|
$ |
8,062
|
||||||
Unallocated
items:
|
||||||||||||
Interest
and other income
|
3,253
|
|||||||||||
Foreign
exchange loss
|
(595 | ) | ||||||||||
Earnings
before income taxes
|
10,720
|
|||||||||||
Income
taxes
|
2,585
|
|||||||||||
Net
earnings for the year
|
$ |
8,135
|
||||||||||
Government
grants (note 15)
|
$ | (1,307 | ) | $ |
−
|
$ | (1,307 | ) | ||||
|
||||||||||||
Amortization
of capital assets
|
$ |
6,689
|
$ |
1,228
|
$ |
7,917
|
||||||
Stock-based
compensation costs
|
$ |
962
|
$ |
70
|
$ |
1,032
|
||||||
Impairment
of long-lived assets (note 4)
|
$ |
−
|
$ |
604
|
$ |
604
|
||||||
Capital
expenditures
|
$ |
3,049
|
$ |
329
|
$ |
3,378
|
Year
ended August 31, 2005
|
||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
||||||||||
Sales
|
$ |
80,120
|
$ |
17,096
|
$ |
97,216
|
||||||
Earnings
(loss) from operations
|
$ |
763
|
$ | (962 | ) | $ | (199 | ) | ||||
Unallocated
items:
|
||||||||||||
Interest
and other income
|
2,524
|
|||||||||||
Foreign
exchange loss
|
(1,336 | ) | ||||||||||
Earnings
before income taxes
|
989
|
|||||||||||
Income
taxes
|
2,623
|
|||||||||||
Net
loss for the year
|
$ | (1,634 | ) | |||||||||
Amortization
of capital assets
|
$ |
6,504
|
$ |
2,588
|
$ |
9,092
|
||||||
Stock-based
compensation costs
|
$ |
897
|
$ |
66
|
$ |
963
|
||||||
Capital
expenditures
|
$ |
1,408
|
$ |
93
|
$ |
1,501
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Telecom
Division
|
$ |
109,065
|
$ |
93,853
|
||||
Life
Sciences and Industrial Division
|
9,199
|
11,339
|
||||||
Unallocated
assets
|
160,874
|
113,967
|
||||||
$ |
279,138
|
$ |
219,159
|
As
at August 31,
|
||||||||
2007
|
2006
|
|||||||
Telecom
Division
|
$ |
23,622
|
$ |
22,545
|
||||
Life
Sciences and Industrial Division
|
4,815
|
4,597
|
||||||
$ |
28,437
|
$ |
27,142
|
Years
ended August 31,
|
||||||||||||
2007
|
2006
|
2005
|
||||||||||
United
States
|
$ |
73,679
|
$ |
59,457
|
$ |
56,282
|
||||||
Canada
|
9,619
|
8,767
|
6,830
|
|||||||||
Latin
America
|
7,592
|
8,380
|
3,127
|
|||||||||
Americas
|
90,890
|
76,604
|
66,239
|
|||||||||
Europe-Middle
East-Africa
|
41,270
|
32,379
|
19,396
|
|||||||||
Asia-Pacific
|
20,774
|
19,270
|
11,581
|
|||||||||
$ |
152,934
|
$ |
128,253
|
$ |
97,216
|
As
at August 31,
|
||||||||||||||||||||||||
2007
|
2006
|
|||||||||||||||||||||||
Property,
plant and equipment
|
Intangible
assets
|
Goodwill
|
Property,
plant and equipment
|
Intangible
assets
|
Goodwill
|
|||||||||||||||||||
Canada
|
$ |
16,434
|
$ |
9,580
|
$ |
24,801
|
$ |
17,364
|
$ |
10,690
|
$ |
23,670
|
||||||||||||
United
States
|
13
|
21
|
3,636
|
28
|
258
|
3,472
|
||||||||||||||||||
China
|
1,670
|
27
|
–
|
–
|
–
|
–
|
||||||||||||||||||
$ |
18,117
|
$ |
9,628
|
$ |
28,437
|
$ |
17,392
|
$ |
10,948
|
$ |
27,142
|
Years
ended August 31,
|
||||||||||||||||
2007
|
2006
|
2005
|
||||||||||||||
Net
earnings (loss) for the year in accordance with Canadian
GAAP
|
$ |
42,275
|
$ |
8,135
|
$ | (1,634 | ) | |||||||||
Unrealized
losses on available-for-sale securities
|
a | ) |
55
|
–
|
–
|
|||||||||||
Stock-based
compensation costs related to stock appreciation rights
|
b | ) | (73 | ) |
–
|
–
|
||||||||||
Unrealized
losses on forward exchange contracts
|
c | ) |
–
|
–
|
(1,286 | ) | ||||||||||
Net
earnings (loss) for the year in accordance with U.S. GAAP
|
42,257
|
8,135
|
(2,920 | ) | ||||||||||||
Other
comprehensive income (loss)
|
||||||||||||||||
Foreign
currency translation adjustment
|
9,218
|
12,322
|
15,669
|
|||||||||||||
Unrealized
losses on available-for-sale securities
|
a | ) | (55 | ) |
–
|
–
|
||||||||||
Unrealized
gains (losses) on forward exchange contracts
|
c | ) | (1,548 | ) |
5,394
|
2,313
|
||||||||||
Reclassification
of realized gains on forward exchange contracts in net earnings
(loss)
|
c | ) | (1,039 | ) | (2,880 | ) | (65 | ) | ||||||||
Future
income taxes on unrealized gains on forward exchange
contracts
|
d | ) | (916 | ) |
–
|
–
|
||||||||||
Comprehensive
income
|
$ |
47,917
|
$ |
22,971
|
$ |
14,997
|
||||||||||
|
||||||||||||||||
Basic
and diluted net earnings (loss) per share in accordance with
U.S.
GAAP
|
$ |
0.61
|
$ |
0.12
|
$ | (0.04 | ) | |||||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,875
|
68,643
|
68,526
|
|||||||||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,555
|
69,275
|
68,526
|
As
at August 31,
|
||||||||||||||||
2007
|
2006
|
2005
|
||||||||||||||
Shareholders’
equity in accordance with Canadian GAAP
|
$ |
250,165
|
$ |
196,234
|
$ |
173,400
|
||||||||||
Forward
exchange contracts
|
c | ) |
2,864
|
5,451
|
2,937
|
|||||||||||
Goodwill
|
e | ) | (12,697 | ) | (11,908 | ) | (11,042 | ) | ||||||||
Future
income tax assets
|
d | ) | (916 | ) |
–
|
–
|
||||||||||
Stock
appreciation rights
|
b | ) | (73 | ) |
–
|
–
|
||||||||||
|
||||||||||||||||
Shareholders’
equity in accordance with U.S. GAAP
|
$ |
239,343
|
$ |
189,777
|
$ |
165,295
|
Share
capital
|
Contributed
surplus
|
Deficit
|
Deferred
stock-based compensation costs
|
Other
capital
|
Accumulated
other comprehensive income
|
Shareholders’
equity
|
||||||||||||||||||||||
Balance
as at August 31, 2004
|
$ |
596,309
|
$ |
1,537
|
$ | (464,159 | ) | $ | (939 | ) | $ |
4,669
|
$ |
11,877
|
$ |
149,294
|
||||||||||||
Net
loss for the year
|
−
|
−
|
(2,920 | ) |
−
|
−
|
−
|
(2,920 | ) | |||||||||||||||||||
Stock-based
compensation costs
|
1,213
|
−
|
−
|
(776 | ) |
425
|
−
|
862
|
||||||||||||||||||||
Foreign
currency translation adjustment
|
−
|
−
|
−
|
−
|
−
|
15,669
|
15,669
|
|||||||||||||||||||||
Unrealized
gains on forward exchange contracts
|
−
|
−
|
−
|
−
|
−
|
2,248
|
2,248
|
|||||||||||||||||||||
Exercise
of stock options
(note
13)
|
148
|
−
|
−
|
−
|
−
|
−
|
148
|
|||||||||||||||||||||
Share
issue expenses (note 13)
|
(6 | ) |
−
|
−
|
−
|
−
|
−
|
(6 | ) | |||||||||||||||||||
Balance
as at August 31, 2005
|
597,664
|
1,537
|
(467,079 | ) | (1,715 | ) |
5,094
|
29,794
|
165,295
|
|||||||||||||||||||
Net
earnings for the year
|
−
|
−
|
8,135
|
−
|
−
|
−
|
8,135
|
|||||||||||||||||||||
Stock-based
compensation costs
|
−
|
−
|
−
|
−
|
954
|
−
|
954
|
|||||||||||||||||||||
Reclassification upon
adoption of SFAS 123(R)
|
−
|
−
|
−
|
1,715
|
(1,715 | ) |
−
|
−
|
||||||||||||||||||||
Foreign
currency translation adjustment
|
−
|
−
|
−
|
−
|
−
|
12,322
|
12,322
|
|||||||||||||||||||||
Unrealized
gains on forward exchange contracts
|
−
|
−
|
−
|
−
|
−
|
2,514
|
2,514
|
|||||||||||||||||||||
Exercise
of stock options
(note
13)
|
557
|
−
|
−
|
−
|
−
|
−
|
557
|
|||||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock
awards
(note
13)
|
200
|
−
|
−
|
−
|
(200 | ) |
−
|
−
|
||||||||||||||||||||
Balance
as at August 31, 2006
|
598,421
|
1,537
|
(458,944 | ) |
−
|
4,133
|
44,630
|
189,777
|
||||||||||||||||||||
Net
earnings for the year
|
−
|
−
|
42,257
|
−
|
−
|
−
|
42,257
|
|||||||||||||||||||||
Stock-based
compensation costs
|
−
|
−
|
−
|
−
|
847
|
−
|
847
|
|||||||||||||||||||||
Foreign
currency translation adjustment
|
−
|
−
|
−
|
−
|
−
|
9,218
|
9,218
|
|||||||||||||||||||||
Unrealized
losses on
available-for-sale
securities
|
−
|
−
|
−
|
−
|
−
|
(55 | ) | (55 | ) | |||||||||||||||||||
Unrealized
losses on forward exchange contracts
|
−
|
−
|
−
|
−
|
−
|
(2,587 | ) | (2,587 | ) | |||||||||||||||||||
Future
income taxes on unrealized gains on forward exchange
contracts
|
−
|
−
|
−
|
−
|
−
|
(916 | ) | (916 | ) | |||||||||||||||||||
Exercise
of stock options
(note
13)
|
802
|
−
|
−
|
−
|
−
|
−
|
802
|
|||||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock awards
(note
13)
|
296
|
−
|
−
|
−
|
(296 | ) |
−
|
−
|
||||||||||||||||||||
Balance
as at August 31, 2007
|
$ |
599,519
|
$ |
1,537
|
$ | (416,687 | ) | $ |
−
|
$ |
4,684
|
$ |
50,290
|
$ |
239,343
|
As
at August 31,
|
||||||||||||||||
2007
|
2006
|
2005
|
||||||||||||||
Foreign
currency translation adjustment
|
||||||||||||||||
Current
year
|
$ |
9,218
|
$ |
12,322
|
$ |
15,669
|
||||||||||
Cumulative
effect of prior years
|
39,179
|
26,857
|
11,188
|
|||||||||||||
48,397
|
39,179
|
26,857
|
||||||||||||||
Unrealized
losses on available-for-sale securities
|
a | ) | ||||||||||||||
Current
year
|
(55 | ) |
−
|
−
|
||||||||||||
Unrealized
gains on forward exchange contracts
|
c | ) | ||||||||||||||
Current
year
|
(2,587 | ) |
2,514
|
2,248
|
||||||||||||
Cumulative
effect of prior years
|
5,451
|
2,937
|
689
|
|||||||||||||
2,864
|
5,451
|
2,937
|
||||||||||||||
Future
income taxes on unrealized gains on forward exchange
contracts
|
d | ) | ||||||||||||||
Current
year
|
(916 | ) |
−
|
−
|
||||||||||||
$ |
50,290
|
$ |
44,630
|
$ |
29,794
|
a)
|
Short-term
investments
|
b)
|
Stock-based
compensation costs related to stock appreciation
rights
|
c)
|
Forward
exchange contracts
|
d)
|
Future
income taxes
|
e)
|
Goodwill
|
f)
|
Research
and development tax
credits
|
g)
|
Elimination
of deficit by reduction of share
capital
|
h)
|
New
accounting standards and
pronouncements
|